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The p75 neurotrophin receptor (p75NTR) is responsible for implementing 
cellular death during embryonic development and in response to cellular injury. The 
receptor has been recognized as a contributor of neurodegeneration in numerous 
pathological conditions. Cleavage of p75NTR by Tumor Necrosis Factor converting 
enzyme (TACE) and γ-secretase has been observed to be associated with an increase in 
neurodegeneration. In a previous study, p75NTR was discovered to become activated in 
sympathetic neurons in response to oxidative stress induced by 4-hydroxynonenal 
(HNE) in a ligand-independent mechanism. Furthermore, cleavage of the receptor was 
demonstrated to contribute to the death of sympathetic neurons following oxidative 
insult. This study investigates the effects of oxidative stress on p75NTR signaling in 
dopaminergic neurons. Because dopaminergic neurons only compromise a very small 
percentage of the ventral midbrain, the Lund Human Mesencephalic cell line 
(LUHMES) was used in our study. LUHMES cells can be differentiated into mature 
dopaminergic neurons following a two-step differentiation procedure. The p75NTR was 
found to be activated and cleaved in response to 6-hydroxydopamine (6-OHDA), a 
neurotoxin frequently used to mimic oxidative stress in dopaminergic neurons. 
Furthermore, the pretreatment of dopaminergic neurons with a ligand-blocking 
antibody specific for the extracellular domain of p75NTR (α- p75 NTR ECD) failed to 
protect neurons from 6-OHDA-induced death. Our results suggest that p75NTR may 
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The majority of neurons that compromise both divisions of the nervous system, 
the central and peripheral nervous systems, are made up of a cell body and its 
appendages called dendrites and axons. Neurons are responsible for receiving 
information through their dendrites, which can lead to the stimulation or inhibition of 
neuron electrical impulses. In an excited neuron, an action potential is generated, 
which is conducted down the axon. Axons are insulated with myelin, a fatty substance 
that wraps around the axon and enhances action potential propagations quickly and 
sufficiently. At the end of the axon, there are branches called axon terminals, which 
are responsible for communicating to specific target cells and tissues. These neuronal 
connections are termed synapses, and these are the sites in which information is 
carried from the first neuron to the target neuron, also known as the pre- and 
postsynaptic neurons, respectively. The overall health of neurons is reliant on proper 
growth, differentiation, and function which can be sufficiently provided by specific 
growth factors. 
Neurotrophins are a family of neuronal growth factors that regulate neuronal 
growth, development, differentiation, and plasticity(E. J. Huang & Reichardt, 2001; 
Sorkin & von Zastrow, 2002). Their presence has been characterized as a necessity for 
the survival of developing neurons in which limited quantity of neurotrophins during 
development can severely affect the number of surviving neurons(Skaper, 2018). 
Additionally, alterations of neurotrophin levels have been connected to 
neurodegenerative diseases such as Alzheimer’s and Huntington’s disease, as well as 
mental illnesses like substance abuse and depression(M. V. Chao, Rajagopal, & Lee, 
2006). The four members of the neurotrophin family include Nerve Growth Factor 
(NGF), Brain-Derived Neurotrophin Factor (BDNF), Neurotrophin-3 (NT-3), and 
Neurotrophin-4 (NT-4). Initially, all four neurotrophins are synthesized as precursors 
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until they are enzymatically cleaved to yield the mature neurotrophin form (Ramee 
Lee, Kermani, Teng, & Hempstead, 2001). Within the Golgi apparatus and endoplasmic 
reticulum, proneurotrophins can be proteolytically cleaved by furin and pro-protein 
convertases (Seidah et al., 1996). Alternatively, proneurotrophins can be secreted into 
the extracellular cleavage and be cleaved by plasmin and matrix mellatoproteases 
thereby releasing mature neurotrophins (R Lee, Kermani, Teng, & Hempstead, 2001). 
At this point, mature neurotrophins can then exert their survival-promoting effects by 
binding to one or more of the three members of the Tropomyosin Related Kinases 
(Trk) receptor family, TrkA, TrkB, or TrkC (M. V. Chao et al., 2006; E. J. Huang & 
Reichardt, 2001; Sorkin & Zastrow, 2002).  
Nerve Growth Factor (NGF) was the first neurotrophin to be discovered and it is 
the most well characterized member of the neurotrophin family (M. V. Chao et al., 
2006). Upon NGF’s discovery, the role of cellular interactions was revealed and the 
“neurotrophic hypothesis” was established (Raff et al., 1993). The neurotrophic 
hypothesis entails that during nervous system development, a retrograde flow of 
neurotrophic factors is formed, in which NGF travels from the post-synaptic neuron or 
target tissue to the cell body of the presynaptic neuron. Neurons that successfully 
form this retrograde flow survive developmental death while neurons that fail to do so 
die. This retrograde flow of NGF must consistently occur throughout life in order for 
the neuron to remain functional. Confirmations of the neurotrophic hypothesis have 
been investigated, in which removal of post-synaptic neurons results in the death of 
the developing pre-synaptic neurons that should innervate the target (Raff et al., 
1993). Additionally, augmenting NGF to the target area of innervation rescued neurons 
that would have otherwise resulted in death (Hamburger, Brunso-Bechtold, & Yip, 
1981).  
NGF serves as a trophic factor that is able to bind and activate TrkA to mediate 
the proper development, maintenance, and survival of various types of neurons such 
as sympathetic, peripheral sensory and cholinergic neurons(Dreyfus, 1989). For 
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example, NGF has been shown to regulate proper differentiation of neurons during 
development (Skaper, 2018). Furthermore, NGF has been characterized as a promoter 
of neurite outgrowth in sympathetic and sensory ganglia during development(Viktor & 
Rita, 2018). As neurons mature, they begin to lose their dependency on NGF for 
survival. However, NGF has also been shown to promote survival effects in adult 
neurons. For example, NGF has been suggested to promote the survival and 
regeneration of injured neurons (Korsching, 1993). Following peripheral nerve injury, 
the release of cytokines has been demonstrated to promote the synthesis of NGF in 
Schwann cells, fibroblasts, and mast cells within the injured nerve (Korsching, 1993). 
Furthermore, NGF has been shown to induce sensitization of nociceptive neurons 
during inflammation by increasing the expression of proinflammatory molecules and 
specific ion channels (Vivas, Kruse, & Hille, 2014). NGF has been shown to modulate 
synaptic transmission of cholinergic neurons by promoting the synthesis of 
Acetylcholine (Hefti, 1986), a neurotransmitter responsible for stimulating muscle 
contraction.  
Aside from NGF, neurons have also been shown to also express other 
neurotrophins such as NT-4 and BDNF(Ibáñez, 1995), which bind and activate TrkB 
with similar affinity(Proenca et al., 2017). However, the functions they each mediate 
are distinct. For example, BDNF is notoriously recognized as a critical modulator of 
synaptic plasticity(Ibáñez, 1995; Proenca et al., 2017) and higher order cognitive 
functions(Zhe-Yu Chen et al., 2006) whereas the role of NT-4 in synaptic transmission is 
less known. NT-4 has been revealed as a regulator for the proper development and 
maintenance of preganglionic sympathetic neurons extending from the spinal cord to 
innervate their sympathetic targets(Roosen et al., 2001; Schober et al., 1998). There is 
evidence indicating that the reason behind the diverse biological functions of BDNF 
and NT-4 is due to the difference in endocytic sorting of the TrkB receptor once bound 
and activated(Proenca et al., 2017). BDNF has also been observed to promote stem cell 
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differentiation in rat adipose derived stem cells by exerting a synergistic effect with 
NT-3 (Ji, Zhang, Ji, Wang, & Qiu, 2015).  
The neurotrophic activity of NT-3 is broad, ranging from involvement in 
peripheral nerve repair (Midha, Munro, Dalton, Tator, & Shoichet, 2003; Sterne, 
Brown, Green, & Terenghi, 1997), to enforcing the formation of neuronal synapses 
(Maisonpierre et al., 2018). NT-3 has been described to have an important role in the 
development and differentiation of enteric neurons and glial cells, as well as the 
promotion of mitosis in neural crest cells (Gao, Wei, Wang, Wu, & Zhu, 2012). NT-3 is 
commonly used to induce the differentiation of stem cells into neurons (Gao et al., 
2012). A partial reason as to why the biological functions of NT-3 are so broad may be 
due to its broad specificity for more than one Trk receptor.  Typically, members of the 
neurotrophin family bind and activate only one of the three members of the Trk 
family. NT-3 characteristically binds and activates TrkC. However, NT-3 has been 
observed to activate other Trk receptors with less efficiency (Reichardt, 2006). For 
example, in a study conducted by Yancopoulous and colleagues, the specificity of NT-3 
was assessed by comparing the ability of NT-3 to promote neurite outgrowth with NGF 
and BDNF in two different neuronal cell populations (Maisonpierre et al., 2018).  BDNF 
and NGF were shown to only have the ability to promote neurite outgrowth in one of 
the two neuronal cell populations (Maisonpierre et al., 2018). However, NT-3 was able 
to promote neurite outgrowth in both cell populations. These results indicate that NT-
3 likely has a broader binding specificity compared to other neurotrophins, meaning 
the neurotrophin can bind to more than one type of Trk receptor. Nonetheless, NT-3 
has been dubbed as an essential protein for the survival and growth of developing 
neurons during the embryonic stages of life(Fox & McAdams, 2010; Sahenk et al., 
2010).  
1.2 Neurotrophin Receptors 
Trk receptors are a class of receptors that belong to the larger family of 
Receptor Tyrosine Kinases (RTKs) (Sorkin & von Zastrow, 2002). Trk receptors exist as 
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dimers and have intrinsic tyrosine kinase activity. The structure of Trk receptors 
includes an extracellular domain containing a cysteine rich cluster followed by three 
leucine rich repeats, a second cysteine rich cluster, and two immunoglobulin-like 
domains (M. V. Chao & Hempstead, 1995; Iacaruso et al., 2011). The cytoplasmic 
region of Trk receptors contains a tyrosine kinase domain which can phosphorylate 
and dimerize in response to neurotrophin binding (Sorkin & von Zastrow, 2002). The 
binding of neurotrophins to Trk receptors has been shown to lead to the activation of 
the proteins Ras, phosphatidylinositol 3-kinase (PI3-K), and phospholipase C-γl, as well 
as signaling pathways that include these proteins (Skaper, 2018). 
The mechanics of Trk signaling have been widely established (Zweifel, Kuruvilla, 
& Ginty, 2005), which involves the retrograde transport of neurotrophins from 
postsynaptic neurons to the cell bodies of presynaptic neurons by way of the axon 
(Vivas et al., 2014). Experiments utilizing compartmentalized neuronal cultures 
demonstrated that the direct application of NGF to distal axons supported the 
extension of axons to their final targets (Zweifel et al., 2005). In contrast, the direct 
application of NGF to cell bodies prevented axons from being able to innervate their 
targets leading neurons to death (Zweifel et al., 2005). The removal of NGF from distal 
axons caused axons to retract and degenerate, ultimately causing neuronal death. 
However, the direct application of NGF to cell bodies allowed neurons to survive. 
Therefore, it was established that in order for neurons to survive and successfully 
innervate their specific targets, neurotrophins must be retrogradely transported from 
distal axons to neuronal cell bodies (Zweifel et al., 2005). The mechanism at which this 
retrograde signaling occurs has been demonstrated to occur by way of the endocytic 
pathway. A significant amount of evidence indicates that the binding of neurotrophins 
to a Trk receptor causes the ligand-bound receptor to become internalized and 
retrogradely transported to the neuronal cell body through the axon via a ‘signaling 
endosome’ (Zweifel et al., 2005). However, the exact consensus of the signaling 
endosome remains vague. 
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Nevertheless, Trk receptor activation has been shown to stimulate endocytosis 
leading to the engulfment of activated Trk receptors by clathrin-coated pits (Saxena et 
al., 2005; Sorkin & von Zastrow, 2009). The internalized Trk receptors are then passed 
on to sorting endosomes where they meet their fate via a recycling or degradative 
pathway (Saxena et al., 2005; Sorkin & von Zastrow, 2009). If Trk receptors are 
recycled, they are returned to the plasma membrane of the cell where they can then 
undergo ligand induced activation once again. The degradative pathway leads Trk 
receptors to multivesicular bodies, also known as late endosomes, which are believed 
to terminate the functions of the receptor by blocking any potential neurotrophin 
binding (Saxena et al., 2005). The catalytic activity of Trk receptors has been observed 
to correlate with endocytosis in which this correlation has been described as a 
“homeostatic regulatory loop”(Sorkin & von Zastrow, 2009). Endocytosis is said to 
control cell signaling by regulating the number of available Trk receptors within the 
plasma membrane for activation. Comparatively, activated Trk receptors trigger 
endocytosis to occur to help prevent excessive cell signaling activation (Sorkin & von 
Zastrow, 2009).  Additionally, endocytosis is believed to alter the concentration of 
ligand required for Trk receptor activation in order to control the strength or duration 
of many cell signaling pathways (Sorkin & von Zastrow, 2009).  
The signaling activities of Trk receptors, particularly TrkA, can be enhanced 
under the presence of a second receptor known as the p75 neurotrophin receptor 
(p75NTR) (Iacaruso et al., 2011). The initial discovery of NGF led to the encounter of 
p75NTR due to the observation that NGF could bind two distinct sites, one of high 
affinity and the other of low affinity (Sutter, Riopelle, Harris-Warrick, & Shooter, 1979).  
After numerous investigations, scientists began to question if the two receptors 
worked together to mediate the survival effects of NGF since both receptors are co-
expressed in many cell types. Interestingly enough, co-expression of p75NTR and TrkA 
was identified to produce a high affinity binding for NGF which led to the 
enhancement of Trk signaling (M. V. Chao & Hempstead, 1995).  Remarkably, the 
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differential expression of p75NTR was shown to alter Trk receptor signaling. For 
example, the reduction of p75NTR expression (Benedetti, Levi, & Chao, 1993) or the 
inhibition of p75NTR with functional-blocking antibodies (Barker & Shooter, 1994; 
Philippe P Roux & Barker, 2002) led to a reduction in Trk receptor expression as well as 
in a reduction of Trk receptor responsiveness to NGF. Furthermore, the coexpression 
of p75NTR and TrkA has been suggested to contribute the massive loss of peripheral 
neurons and decreased skin innervation observed in adult p75NTR knockout mice (K. 
Lee et al., 1992).   
Although there is an extensive amount of research stating that the interactions 
between p75NTR and TrkA result in increased responsiveness for NGF, the exact 
mechanism through which these two receptors interact with each other has not been 
completely illuminated. However, there are two proposed mechanisms for the two-
receptor system. The first, referred to as the ‘ligand passing mechanism,’ suggests that 
the expression of p75NTR with TrkA allows the two receptors to interact with each 
other, leading to an increase in the local concentration of NGF. NGF will initially bind to 
p75NTR, but then bind to TrkA with greater stability (Barker & Shooter, 1994). The 
second mechanism, termed the ‘heterodimer mechanism,’ hypothesizes that p75NTR 
and TrkA form a heterodimer that leads to an induction of NGF. The presence of NGF 
causes the two receptors to dissociate, further leading to TrkA to undergo a 
conformational change that is highly favored by NGF. Consequently, this allosteric 
regulation allows NGF to only bind to TrkA (Esposito et al., 2001).  
A variety of characteristics about p75NTR led investigators to further explore the 
receptor’s individual role in neurotrophin signaling. For example, the level of co-
expression of TrkA has a major impact on the survival signals p75NTR mediates. In the 
absence of TrkA, the binding of NGF to p75NTR initiates apoptosis (María Frade, 
Rodríguez-Tébar, & Barde, 1996). However, co-expression allows p75NTR to mediate 
cell differentiation and neuronal cell survival (María Frade et al., 1996). Additionally, 
p75NTR is widely distributed among numerous cell types, such as fibroblasts 
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(Dobrowsky, Jenkins, & Hannun, 1995), oligodendrocytes (Casaccia-Bonnefil, Carter, 
Dobrowsky, & Chao, 1996), Schwann cells (Carter et al., 1996), as well as throughout 
both divisions of the developing nervous system (Ernfors et al., 1991). In contrast, TrkA 
expression is limited to cholinergic neurons of the basal forebrain (Holtzman et al., 
1995). Although, p75NTR is recognized to lack a signaling domain (Dobrowsky et al., 
1995), the receptor has been shown to mediate several cellular responses such as 
myelination(Chan et al., 2004), axonal outgrowth (Marushige, Raju, Marushige, & 
Koestner, 1987), cell cycle regulation (Verbeke et al., 2010), and Schwann cell 
migration (Anton, Weskamp, Reichardt, & Matthew, 1994), as well as initiating the 
activation of several intracellular signaling pathways such as NF-κB (Carter et al., 1996), 
c-jun terminal kinase (JNK) (Casaccia-Bonnefil et al., 1996), and caspases (Gu, Casaccia-
bonnefil, Srinivasan, & Chao, 1999).  
1.3 Structure of p75NTR 
 The p75NTR is a Type I transmembrane protein that belongs to the tumor 
necrosis factor receptor (TNFR) superfamily (Rodriguez-Tébar, Dechant, & Barde, 1990; 
Squinto et al., 1991) and it has the ability to bind all four members of the neurotrophin 
family (Rodriguez-Tébar et al., 1990). The extracellular domain (ECD) of p75NTR is made 
up of four cysteine rich domains, which serves as the ligand-binding domain of p75NTR 
and is a distinguished feature of all TNFR family members (Barker, 1998). Similar to Trk 
receptors, p75NTR undergoes ligand-induced dimerization which can lead to the 
activation of various intracellular signaling pathways (Yano & Chao, 2000). This 
mechanism through which p75NTR becomes activated in response to neurotrophin 
binding has been proposed as “the snail-tong model” (Marçal Vilar et al., 2009). Within 
this model, the activation of p75 is suggested to occur through a ligand-induced 
rearrangement of disulfide-linked receptor subunits in a scissors-like movement. The 
proposed mechanism states that when the neurotrophin binds to the ECD of p75, the 
two ECD subunits move closer together while the two ICD subunits separate. The 
disulfide-linked subunits of the transmembrane domain are thought to act as a 
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fulcrum. The separation of the two ICD subunits is suggested to facilitate the activation 
of various downstream signaling events (Marçal Vilar et al., 2009). 
Although p75NTR has been recognized to lack intrinsic catalytic activity, the 
intracellular domain of the receptor (ICD) has been suggested to contain regions that 
can interact with various adaptor proteins to mediate several down-stream signaling 
events leading to cell death (Philippe P Roux & Barker, 2002). For example, the ICD of 
p75NTR contains an additional notable feature of the TNFR family known as the ‘death 
domain’ (Barker, 1998; Philippe P Roux & Barker, 2002) The death domains of the 
related TNFR family members Fas and TNFR1 have been identified to interact with 
adaptor proteins that link the receptors to caspase activation, ultimately resulting in 
programmed cell death (Hofmann & Tschopp, 1995). However, the death domain of 
p75NTR has been shown to function differently. For example, the death domains of 
TNF1 and Fas are able to interact with death domain effector proteins such as TRADD 
and FADD, leading to the activation of the extrinsic apoptotic signaling cascade. 
Analysis of the p75NTR death domain using NMR spectroscopy revealed that the 
receptor’s death domain is unable to interact with death domain effector proteins 
(Liepinsh, Ilag, Otting, & Ibáñez, 1997). Furthermore, p75NTR has been shown that it is 
actually unable to cause activation of the extrinsic apoptotic signaling cascade (Gu et 
al., 1999). Despite functional differences between the death domain of p75NTR and the 
death domains of other TNF receptors, the p75NTR death domain has been shown to be 
necessary for the induction of apoptosis. A significant reduction of neuronal death in 
the hippocampus, somatosensory, piriform, and entorhinal cortices was observed in 
mutant mice lacking the p75NTR death domain compared to wild-type controls (Tanaka, 
Kelly, Goh, Lim, & Ibáñez, 2016).  
The death domain of p75NTR is connected to the transmembrane domain of the 
receptor by a flexible juxtamembrane region termed the ‘chopper domain.’ This region 
of p75NTR has also been implicated in promotion of cell death through caspase 
activation in a variety of neuronal and non-neuronal cell types such as dorsal root 
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ganglion, Schwann cells, and fibroblasts (E J Coulson et al., 2000).  The chopper domain 
has been suggested to be necessary for the initiation of p75NTR-mediated cell death 
due to the inability of peripheral neurons transfected with mutant constructs lacking 
the chopper domain to undergo apoptosis (E J Coulson et al., 2000).  However, there 
still remains much controversy regarding the juxtamembrane of the receptor and the 
structural component of p75NTR responsible for mediating cell death since a recent 
investigation conducted by Ibanez and colleagues revealed that a p75NTR construct 
deficient in the chopper domain but abundant in the death domain resulted in the 
inability of p75NTR to induce cell death (Tanaka et al., 2016).  
1.4 p75NTR Mediates Cell Death 
There are numerous in vivo and in vitro studies showing that p75NTR has a role 
in promoting apoptosis, but the precise mechanism underlying this function remains 
unclear. Due to the ability of p75NTR to attenuate Trk receptor function, it has been 
often difficult to interpret whether the receptor can actually facilitate pro-apoptotic 
effects on its own. However, the pro-apoptotic functions of p75NTR have been better 
understood by the initiation of neurotrophin withdrawal (Rabizadeh et al., 2017). The 
expression of p75NTR in immortalized neural cells cultured in medium containing serum 
had no effect on death. However, when serum was withdrawn, the expression of 
p75NTR in these cells resulted in death (Rabizadeh et al., 2017). Remarkably, the 
addition of NGF to the cells following serum withdrawal lead to suppressed cell death 
(Rabizadeh et al., 2017). Similar results were seen in sympathetic neurons (Rukenstein, 
Rydel, & Greene, 1991) and differentiated PC12 cells (Rabizadeh et al., 2017). The 
withdrawal of NGF from culture medium led to the death of PC12 cells and 
sympathetic neurons. However, the addition of NGF following withdrawal resulted in 
suppressed cell death (Rabizadeh et al., 2017; Rukenstein et al., 1991).   
The ability of p75NTR to induce cell death has been further exemplified in 
knockout mouse models (Miller & Kaplan, 2001). The four cysteine rich domains 
localized on ECD of p75NTR serve as the ligand binding domain for the receptor and are 
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encoded by exonIII. The first p75NTR knockout mouse model was generated by 
abolishing the exonIII gene (K. Lee et al., 1992). As a result, newborn p75NTR/exonIII pups 
exhibited a greater number of sympathetic neurons, providing the first line of evidence 
that p75NTR plays a role in apoptosis during development (K. Lee et al., 1992). Naturally 
occurring cell death is a significant feature of nervous system development. The 
process ensures appropriate neuronal connections are made and that the appropriate 
cell number is generated among neural tissues in order to cultivate a properly 
functioning nervous system. Further investigations utilizing p75NTR knockout mice 
established the receptor as a critical regulator of neurodevelopment through the 
promotion of naturally occurring cell death within the basal forebrain (Naumann et al., 
2002), superior cervical ganglion (Bamji et al., 1998), spinal cord (Frade & Barde, 1999), 
and retina(María Frade et al., 1996) during embryonic development. Deletion of the 
receptor within the basal forebrain resulted in an increased number of cholinergic 
neurons (Naumann et al., 2002), thereby suggesting that p75NTR helps mediate normal 
developmental death within this tissue region. 
The pro-apoptotic function of p75NTR has also been identified as a response to 
cellular injury. During development, the expression of p75NTR is elevated but once 
adulthood is reached, levels of the receptor decrease. This observation initially led to 
the idea that the receptor had limited function in the adult nervous system. However, 
the expression of p75NTR has been shown to increase in response to various forms of 
cellular injury such as spinal cord injury (Chu, Yu, & Fehlings, 2007), seizures (Özbas-
Gerçeker et al., 2004; P P Roux, Colicos, Barker, & Kennedy, 1999) and neuronal 
axotomy (Johnson, Hökfelt, & Ulfhake, 1999; Zhou, Rush, & McLachlan, 1996). 
Furthermore, reexpression of the receptor correlated with the induction of apoptosis. 
For example, following spinal cord injury, a higher percentage of cell death was 
observed in rat oligodendrocytes expressing p75 compared to oligodendrocytes not 
expressing the receptor (Chu et al., 2007). Additionally, rats subjected to pilocarpine-
induced seizures resulted in increased expression of p75NTR within the hippocampus, 
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entorhinal cortex, and the piriform cortex which was accompanied with apoptosis (P P 
Roux et al., 1999).  
1.5 Apoptotic Signaling of p75NTR 
Caspases are inactive proenzymes known as cysteine proteases. In order for 
caspases to become activated and induce apoptosis, they must first be cleaved at 
specific aspartic acid residues (Aggarwal, 2000). There are currently 14 known 
members of the caspase family (Gu et al., 1999), which are divided into two main 
groups known as upstream initiators (caspase-2, -8, -9, and -10) and downstream 
executioners (caspase-3, -6, and 7) (Aggarwal, 2000). Upstream initiator caspases 
undergo auto-cleavage to induce their own activation, but they are also responsible 
for cleaving and activating the downstream executioner caspases which ultimately 
trigger the execution phase of apoptosis (Boatright et al., 2003).  
There are two major apoptotic signaling pathways, the extrinsic and intrinsic 
pathways. The two pathways are distinguished by the presence or absence of 
ligand-induced activation of the apoptotic signaling cascade(Elmore, 2007). For 
example, TNF-induced apoptosis has been implicated to be associated with the 
extrinsic apoptotic pathway, which involves the binding of a lethal ligand such as TNF-α 
or Fas, to a TNFR related receptor (Hongmei & Vogt, 2012). Once a death signal has 
bound the receptor, various cytoplasmic adaptor proteins, such as TRADD or FADD 
(Aggarwal, 2000), are recruited to the receptor’s death domain resulting in the 
formation of a death-inducing signaling complex (DISC) (Hongmei & Vogt, 2012). 
Consequently, caspase-8 activation occurs, followed by apoptotic cell death.  
The intrinsic pathway triggers apoptosis through a series of mitochondria 
related events initiated by a wide range of non-receptor mediated stimuli including 
radiation, toxins, hypoxia, and free radicals (Elmore, 2007). Each of these stimuli can 
produce intracellular signals that permeabilize the mitochondrial membrane causing 
the release of the small hemeprotein, cytochrome-c (Elmore, 2007). After its release, 
cytochrome-c joins procaspase-9 to bind to the apoptosis protease activation factor-1 
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(Apaf-1) to produce a wheel-shaped protein complex called the apoptosome (Boatright 
et al., 2003). The apoptosome serves as a large caspase activating complex which first 
cleaves and activates caspase-9 followed by caspase-3 cleavage and activation (Li et al., 
1997).  Cytochrome-c release has also been shown to be regulated by the Bcl-2 protein 
family (Cory & Adams, 2002). The protein family consists of members that either 
promote cell survival or promote cell death (Shamas-Din, Brahmbhatt, Leber, & 
Andrews, 2011). For example, the pro-apoptotic Bcl-2 family members Bax and Bak can 
reduce mitochondrial integrity and cause cytochrome-c release (Gross, McDonnell, & 
Korsmeyer, 1999).  
The cellular mechanisms responsible for initiating the p75NTR-mediated 
apoptotic death cascade remains poorly understood. However, it is almost certain the 
cascade involves caspase activation since caspase inhibitors targeted against 
caspases-1, -3, -6, -7, and -9 prevented p75NTR-mediated cell death from occurring (Gu 
et al., 1999; Troy, Friedman, & Friedman, 2002). The apoptotic pathway induced by 
p75NTR is unique compared to its TNFR relatives. The death domain of p75NTR is unable 
to bind TRADD or FADD, and caspase-8 activation is not apparent in the p75NTR-
mediated apoptotic cascade (Becker, Howell, Kodama, Barker, & Bonni, 2004; Gu et al., 
1999). Furthermore, p75NTR activation was shown to cause mitochondrial release of 
cytochrome-c as well as caspase-9 activation within oligodendrocytes and striatal 
neurons (Becker et al., 2004; Gu et al., 1999). Dominant negative forms of caspase-9 
were shown to attenuate p75NTR-induced death, further indicating that p75NTR initiates 
cell death differently than other TNFR family members (Becker et al., 2004). 
Intriguingly, the p75NTR-apoptotic cascade of oligodendrocytes was shown to consist of 
the same pattern of caspase activation as radiation-induced apoptosis, which requires 
p53, a tumor suppressor protein (Liebermann, Hoffman, & Steinman, 1995).  
The p53 tumor suppressor protein has been indicated as an essential 
downstream component of p75NTR-mediated cell death in sympathetic neurons (Aloyz 
et al., 1998). Typically, p53 initiates apoptosis in response to DNA damage or cellular 
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stress in order to regulate the cell cycle and ultimately prevent tumor formation. 
However, levels of p53 have been shown to increase in response to p75NTR activation 
during neuronal apoptosis (Aloyz et al., 1998). Upregulation of p53 has been implicated 
as a necessity for the occurrence of apoptosis in sympathetic neurons, in which 
inhibition of p53 expression results in the prevention of apoptosis (Aloyz et al., 1998). 
Elevated levels of p53 have been shown to correlate with increased levels of the Bcl-2 
pro-apoptotic protein, Bax, as well as with the hyperphosphorylation of c-jun kinase 
(Aloyz et al., 1998). Consequently, p75NTR is suggested to initiate cell death via the JNK-
p53-Bax pathway even though phosphorylation of c-jun is not required for the 
induction of cell death in sympathetic neurons (Palmada et al., 2002).  
1.6 Signaling Pathways of p75NTR 
The ability of p75NTR to activate sphingomyelin hydrolysis and promote the 
production of ceramide, a second messenger molecule (Dobrowsky et al., 1995), was 
the first piece of evidence demonstrating the receptor could facilitate cellular 
signaling. Before this, p75NTR was thought to only serve as a binding partner for Trk 
receptors that helped lead to Trk receptor activation (M. V. Chao & Hempstead, 1995). 
However, in response to neurotrophin binding, p75NTR activation can lead to the 
production of a ceramide, a bioactive sphingolipid metabolite (Dobrowsky et al., 1995). 
Ceramide has been demonstrated to regulate antimitogenic pathways that result in 
cell growth inhibition, cell differentiation, and apoptosis (Hannun & Linardic, 1993).  
Additionally, ceramide production has been found to result in activation of c-jun N-
terminal kinase (JNK) (Verheij et al., 1996), a stress-activated protein that plays a role 
in triggering apoptosis (Xia Z, Dickens M, Raingeaud J, Davis Rj, & Greenberg Me, 
1995). In response to neurotrophin binding, JNK activation has been observed in 
p75NTR-mediated apoptosis within a variety of cell types including oligodendrocytes 
(Casaccia-Bonnefil et al., 1996), PC12 cells (Philippe P Roux, Bhakar, Kennedy, & Barker, 
2001), sympathetic neurons (Aloyz et al., 1998), and hippocampal neurons (Friedman, 
2000). The use of JNK inhibitors further confirmed the role of JNK in p75NTR-mediated 
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cell death, in which inhibition of upstream JNK activity protected hippocampal neurons 
from p75NTR-mediated cell death (Friedman, 2000).  
Intriguingly, the activation of JNK could only be observed in cells that solely 
expressed p75NTR whereas cells coexpressing TrkA and p75NTR had suppressed JNK 
activity in response to NGF binding (Yoon, Casaccia-Bonnefil, Carter, & Chao, 1998). A 
similar effect was observed in the case of sphingomyelin hydrolysis, in which cells only 
expressing p75NTR were able to produce ceramide (Dobrowsky et al., 1995). 
Furthermore, cells expressing both TrkA and p75NTR failed to undergo sphingomyelin 
hydrolysis (Dobrowsky et al., 1995) and there was an increase in mitogen-activated 
protein kinase (MAPK) activity (Yoon et al., 1998), which is a notable cellular effect 
induced by Trk receptors. These observations led to the speculation that TrkA may 
modulate the signaling activities of p75NTR.  
Consistent with other TNFR family members, p75NTR has the ability to activate 
the Nuclear Factor kappa B (NF-κB) pathway (Carter et al., 1996). Once activated, the 
NF-κB transcription factor has the ability to translocate to the nucleus and promote 
the transcription of various anti-apoptotic genes (Serasanambati & Chilakapati, 2016). 
In Schwann cells, the binding of NGF to p75NTR caused the activation of the NF-κB 
(Carter et al., 1996). Fascinatingly, ceramide treatment was also able to activate the 
NF-κB pathway in p75NTR-expressing Schwann cells (Carter et al., 1996), further 
suggesting the role of NF-κB as an anti-apoptotic signal under stressful cellular 
conditions. A study conducted by Chao and colleagues (Yoon et al., 1998) proposed 
TrkA is able to modulate the survival pathways activated by p75NTR.  For example, the 
lone expression of p75NTR in oligodendrocytes led to an increase in JNK activity 
following NGF binding. However, when p75NTR was coexpressed with TrkA, JNK activity 
was suppressed (Yoon et al., 1998). This result corresponds with the ability of TrkA to 
produce sphingosine-1-phosphate, a sphingolipid that has been shown to support cell 
survival as well as inhibit JNK activity (X. Huang, Withers, & Dickson, 2014). In contrast, 
p75NTR was shown to activate the NF-κB pathway in response to ceramide synthesis in 
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the presence or absence of TrkA expression in oligodendrocytes (Yoon et al., 1998). 
These results suggested that p75NTR survival signals can be controlled by TrkA.  
Ultimately, these results suggested that p75NTR is able to signal through two different 
pathways, JNK and NF-κB, which is characteristic of other TNFR family members. For 
example, the tumor necrosis factor-1 (TNF-1) receptor is able to activate both JNK and 
NF-κB and promote various cellular effects such as cell proliferation, differentiation, 
and apoptosis (Smith, Farrah, & Goodwin, 1994).  
1.7 p75NTR Cytosolic Interactions 
The death domain of p75NTR is structurally homologous to the death domains of 
the TNFR family members, TNFR-1 and Fas (Chapman, 1995). In order to induce cell 
death, most other TNF receptor family members must first dimerize with themselves 
via their death domains. This self-association forms a receptor complex that enables 
the recruitment of death-domain containing adaptor proteins such as TRADD, TRAF, 
RAIDD, FADD, or RIPP (Dempsey, Doyle, He, & Cheng, 2003). The recruitment of these 
adaptor proteins leads to caspase activation and ultimately cell death. Despite 
structural similarities, p75NTR was observed to not induce cell death through the same 
mechanism. Using a yeast-two hybrid assay, p75NTR failed to undergo 
homodimerization as well as failed to interact with FADD, TRADD, RIPP, and RAIDD 
(Nichols, Martinou, Maundrell, & Martinou, 1998). However, p75NTR has been shown 
to successfully bind all six members of the TNFR associated factor (TRAF) protein 
family, leading to either NF-κB activation or cell death induction (Ye et al., 1999).  
The TRAF protein family was the first group of cytosolic interactors identified 
for the p75 neurotrophin receptor (Rothe, Wong, & Goeddel, 1994).  The TRAF 
proteins were isolated based on their ability to interact with the cytoplasmic domains 
of specific TNFR family members (Rothe et al., 1994). TRAF proteins are characterized 
as signal transducers, but not every member of the TRAF protein family mediates the 
same signaling effects. For example, TRAF2, TRAF4, and TRAF6 each modulate NF-κB 
activation. However, the individual coexpression of each of the three TRAF members 
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with p75NTR leads to discrete NF-κB activity. The coexpression of p75NTR with TRAF2 or 
TRAF6 in HEK 293T induced a synergistic effect that results in a significant amount of 
upregulation of NF-κB activation (Ye et al., 1999). Surprisingly, the individual 
coexpression of TRAF6 with p75NTR resulted in a greater synergistic effect on NF-κB 
activation compared to TRAF2 coexpression. In contrast, individual coexpression of 
TRAF4 with p75NTR induced a complete inhibitory effect on p75NTR-mediated activation 
of NF-κB (Ye et al., 1999). 
The interactions of TRAF proteins with p75NTR remain elusive. However, TRAF6 
has gained much recognition as a requirement for the activation of both the NF-κB and 
JNK pathways as well as the activation of p75NTR-mediated apoptosis. The role of 
TRAF6 became more evident when Carter and colleagues showed p75NTR signaling 
deficiencies in in TRAF6 knockout mice (Yeiser, 2004). Wild-type and heterozygous 
TRAF6 mice treated with NGF led to the activation of NF-κB and phosphorylation of 
JNK whereas TRAF6 null mice did not experience the same effects. To ensure that the 
lack of NF-κB and JNK activation were mediated by p75NTR, Carter and colleagues 
treated Schwann cells with TNF, a bioactive cytokine known to activate the NF-κB and 
JNK pathways independent of p75NTR and TRAF6. Remarkably, TRAF6 deficient 
Schwann cells experienced the same amount of NF-κB activation and JNK 
phosphorylation as wild-type Schwann cells (Yeiser, 2004). To further characterize the 
role of TRAF6 in p75NTR-mediated apoptosis, the amount of developmental death that 
occurred within the sympathetic cervical ganglion of TRAF6 knockout mice and wild-
type mice was analyzed. TRAF6 deficient mice experienced a significantly lower 
amount of naturally occurring death compared to TRAF6+/+ counterparts. TRAF6 
knockout mice were observed to have 125% more neurons per ganglia compared to 
wild-type mice (Yeiser, 2004). Astonishingly, these results were similar to those 
observed in p75NTR knockout mice in which there were 130% more neurons per ganglia 
observed in p75NTR null mice compared to their wild-type littermates (Yeiser, 2004).  
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Another adaptor protein found to interact with the intracellular domain of 
p75NTR is the neurotrophin receptor interacting factor (NRIF). NRIF was first identified 
as a necessity for programmed cell death due to the observation of mice lacking the 
NRIF gene experienced a significant reduction in apoptosis within developing retinal 
cells (Casademunt et al., 1999). This result was noticeably similar to p75NTR null mice 
(Frade & Barde, 1999), thus implicating a role for NRIF in developmental programmed 
cell death. NRIF has also been recognized to possibly play a role in initiating death 
through p75NTR in response to injury (Volosin et al., 2008). Interestingly, NRIF knockout 
mice displayed an increase in p75NTR expression in response to seizures, but the 
neurons failed to undergo apoptosis compared to wild-type mice. NRIF was also found 
to participate in p75NTR-mediated cell death in Human embryonic kidney (HEK) 293 
cells by binding to the receptor’s intracellular domain in response to neurotrophin. The 
relevance of this physiological interaction was confirmed by deleting the binding 
region of NRIF to p75NTR which resulted in a reduction of cell death within embryonic 
retina (Casademunt et al., 1999).  
The exact functions of NRIF in p75NTR signaling are not well understood, but it is 
believed that NRIF functions as a transcription factor that translocates to the nucleus 
in order to initiate cell death. An investigation conducted by Carter and colleagues 
displayed a functional interaction between TRAF6 and the NRIF that influenced the 
translocation of NRIF to nucleus as well p75NTR signaling (Gentry, Rutkoski, Burke, & 
Carter, 2004).The direct association between TRAF6 and NRIF was shown to 
dramatically increase the nuclear localization of NRIF as well enhance TRAF6-mediated 
activation of JNK (Gentry et al., 2004). Additionally, p75NTR was only able to induce the 
activation of JNK in response to NGF binding under the presence of both TRAF6 and 
NRIF (Gentry et al., 2004). Thus, the interactions between NRIF and TRAF6 are 
suggested to play an important role in p75NTR-mediated activation of JNK. It has been 
suggested that in response to p75NTR activation, NRIF must first undergo 
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polyubiquination in order to associate with TRAF6 and then translocate to the nucleus 
(Geetha, Kenchappa, Wooten, & Carter, 2005).   
1.8 Proteolytic Cleavage of p75NTR 
 One of the most well-established signaling mechanisms of p75NTR is its 
proteolytic cleavage. The receptor undergoes regulated intramembrane proteolysis 
(RIP), which is carried out by two enzymes, TNFα-converting enzyme (TACE) and 
γ-secretase (K. Jung et al., 2003).  The extracellular domain of p75NTR is first cleaved by 
TACE, thereby causing the release of the receptor’s ectodomain (ECD) as well as 
producing a 25 kDa C-terminal fragment (CTF). Next, the transmembrane region of 
p75NTR is cleaved by γ-secretase, causing the release of a 20 kDa intracellular domain 
fragment (ICD) (K. Jung et al., 2003).  The order that mellatoproteinases cleave p75NTR 
is consistent, with TACE-mediated cleavage occurring prior to γ-secretase-mediated 
cleavage (Zampieri, Xu, Neubert, & Chao, 2005). These sequences of events were 
established with the use of inhibitors, in which cleavage of p75NTR by γ-secretase was 
prevented when TACE activity was blocked. In contrast, the inhibition of γ-secretase 
did not affect TACE function (Zampieri et al., 2005).  
 Cleavage of p75NTR has been demonstrated to contribute to the induction of 
p75NTR-mediated cell death during development as well as in response to cellular 
injuries. For example, p75NTR cleavage has been shown to contribute to developmental 
apoptosis that occurs within the superior cervical ganglion. In rats, superior cervical 
ganglion experience on-going apoptosis at postnatal day 4, but apoptosis subsides at 
postnatal day 24. Remarkably, the CTF and ICD fragments of p75NTR were observed in 
superior cervical ganglia of postnatal day 4 rats but not postnatal day 24 (Kenchappa 
et al., 2006). Proteolytic cleavage of p75NTR has also been observed in neurons 
subjected to injuries such as pilocarpine-seizures (Volosin et al., 2008) and oxidative 
stress(Kraemer et al., 2014). Pilocarpine-seizures have been demonstrated to cause 
the induction of proNGF, a pro-apoptotic ligand and precursor of mature NGF, in 
hippocampal neurons (Volosin et al., 2008).  The treatment of hippocampal neurons 
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with proNGF or NGF resulted in cleavage of p75NTR followed by cell death. Remarkably, 
the application of TACE or γ-secretase inhibitors led to an attenuation of apoptosis in 
hippocampal neurons (Volosin et al., 2008). Similar results were observed in 
sympathetic neurons exposed to oxidative stress (Kraemer et al., 2014), a common 
feature of pathological conditions. These results indicate p75NTR proteolytic cleavage 
must occur in order for p75NTR-mediated cell death to be facilitated.  
The death-inducing ability of the CTF of p75NTR has not been completely 
elucidated, but it has been demonstrated that the juxtamembrane region of the CTF, 
termed the “chopper domain,” activates an apoptotic protease activating factor 
(APAF-1)-dependent death pathway via potassium ionic flux (Elizabeth J Coulson et al., 
2008). This potassium ionic flux has been observed to occur through G-protein-coupled 
inwardly rectifying potassium (GIRK) channels (Elizabeth J Coulson et al., 2008). The 
GIRK channels are potassium-selective ion channels that are widely expressed within 
the developing and adult nervous systems and have been shown to cause neuron 
excitability when activated (S. C. Chen, Ehrhard, Goldowitz, & Smeyne, 1997; Karschin 
& Karschin, 1997; Signorini, Liao, Duncan, Jan, & Stoffel, 1997; Wickman, Karschin, 
Karschin, Picciotto, & Clapham, 2000). Upon neurotrophin binding to p75NTR, GIRK 
channel activation occurs, followed by potassium efflux through the channels. A 
reduction in cytosolic potassium transpires, ultimately promoting the formation of the 
apoptosome and caspase activation (Elizabeth J Coulson et al., 2008). 
 The cleavage fragments produced by regulated intramembrane proteolysis of 
p75NTR have been suggested to serve multiple functions. Firstly, the ECD of p75NTR has 
been suggested to have a neuroprotective role against amyloid-beta (Aβ) toxicity (Yao 
et al., 2015). The restoration of p75NTR-ECD in Alzheimer’s disease mouse models 
resulted in the attenuation of neurite degeneration, neuronal death, and Tau 
phosphorylation (Yao et al., 2015). Secondly, the CTF of p75NTR has been shown to 
promote cell death when it is over-expressed in sensory neurons (E J Coulson et al., 
2000) and PC12 cells (Matusica et al., 2013). For example, PC12 cells overexpressing a 
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protein mimicking the CTF of p75NTR experienced an increased amount of cell death 
compared to several other p75NTR variant constructs (Matusica et al., 2013). Likewise, 
Aβ protein-mediated cell death was observed to correlate with an increased 
production of the p75NTR C-terminal fragment (Sotthibundhu et al., 2008).  
Proteolytic cleavage of p75NTR has been suggested to regulate a variety of cell 
signaling events following generation of the ICD. The ICD of p75NTR has been suggested 
to bind various intracellular proteins and then translocate to the nucleus to initiate 
many downstream signaling events. For example, the ICD has been suggested to 
initiate JNK activation, NRIF translocation (Volosin et al., 2008), and cell cycle arrest 
(Ceni et al., 2010). The inhibition of TACE by TAPI or γ-secretase by DAPT was shown to 
block nuclear translocation of NRIF (Volosin et al., 2008). In addition, the ICD has been 
suggested to play an important role in facilitating Trk signaling events. For instance, 
the overexpression of the p75NTR ICD in PC12 cells was observed to cause Akt 
phosphorylation and PI3K activation (Ceni et al., 2010). When p75NTR expression was 
depleted, there was a significant reduction in Akt phosphorylation. However, the 
restoration of p75NTR ICD expression was able to rescue the signaling defect (Ceni et al., 
2010). Barker and colleagues have proposed a mechanism at which these events occur 
(Kommaddi, Thomas, Ceni, Daigneault, & Barker, 2011a). The proposed model 
suggests that Trk receptor activation causes the phosphorylation of TACE in order to 
initiate p75NTR cleavage. Consequently, p75NTR ICD accumulation occurs, enabling the 
small fragment to facilitate Trk signaling and neurotrophin survival (Kommaddi et al., 
2011a).  
1.9 Proneurotrophins 
 All neurotrophins are initially synthesized as larger precursors of approximately 
30 to 34 kDa (Suter, Heymach, & Shooter, 1991). These larger precursors, known as 
proneurotrophins, can be cleaved by furin and convertases within the endoplasmic 
reticulum or the Golgi apparatus (Heymach & Shooter, 1995) to yield mature 
neurotrophins of approximately 13 kDa (Suter et al., 1991). In addition, 
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proneurotrophins are able to be secreted into the extracellular matrix and then 
cleaved by plasmin and matrix mellatoproteases to yield mature neurotrophins (R Lee 
et al., 2001). Proneurotrophins were initially believed to be biologically inactive. 
Neurotrophin prodomains were initially recognized to only ensure proper protein 
folding and neurotrophin secretion, whereas the mature domain was commonly 
viewed as the secreted ligand responsible for carrying out neurotrophic effects (Suter 
et al., 1991). However, the perplexing ability of neurotrophins to initiate pro-survival 
or pro-survival effects led to the hypothesis that p75NTR could be activated by ligands 
other than neurotrophins (Friedman, 2000). The discovery of proNGF (Ramee Lee et al., 
2001) and proBDNF (H. K. Teng et al., 2005) to selectively bind and activate p75NTR to 
elicit death provided better insight that various neurotrophin isoforms are able to 
mediate a diverse variety of functions.  
 Proneurotrophins are unable to bind and activate Trk receptors, but they have 
been demonstrated to have a high-affinity for p75NTR to induce apoptosis (K. K. Teng, 
Felice, Kim, & Hempstead, 2010). Thus, the biological functions of neurotrophins are 
said to be regulated by their proteolytic cleavage, with immature forms preferentially 
binding to p75NTR to induce death and mature forms binding Trk receptors to induce 
cell survival. Proneurotrophins are able to induce cell death by binding to the high 
affinity receptor complex consisting of p75NTR and Sortilin, a member of the Vps10p-
domain receptor family (Nykjaer, Lee, Teng, & Jansen, 2004). Sortilin recognizes and 
binds the prodomains of proneurotrophins whereas the mature domains of 
proneurotrophins bind to p75NTR. Consequently, the high affinity receptor complex is 
formed and is then able to convey apoptotic signaling through the intrinsic death 
pathway (Nykjaer et al., 2004).  
ProNGF is widely recognized as a pro-apoptotic ligand of p75NTR. The ligand is 
able to mediate its pro-apoptotic signals by binding to the p75NTR-Sortillin complex 
(Nykjaer et al., 2004). In Schwann cells, it has been observed that if one of the 
receptors is absent, then cells are resistant to proNGF-mediated apoptosis (Nykjaer et 
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al., 2004). The death inducing abilities of proNGF have linked to cellular injury and 
disease progression. For example, a study conducted by the Friedman lab 
demonstrated that proNGF is secreted in response to pilocarpine-induced seizure 
(Volosin et al., 2008). Similarly, proNGF secretion could be detected after corticospinal 
injury (Harrington et al., 2004). The induction of proNGF after injury was found to 
cause neuronal death within the hippocampus (Volosin et al., 2008) and the spinal cord 
(Harrington et al., 2004) in which blockage of the ligand’s prodomain was able to 
significantly protect neurons from death (Harrington et al., 2004; Volosin et al., 2008). 
Intriguingly, anti-proNGF treatment was able to prevent p75NTR upregulation from 
occurring within the hippocampus after seizure (Volosin et al., 2008), suggesting the 
pro-apoptotic ligand is able to regulate the induction of the receptor in order to elicit 
apoptosis. Further characterization of the role of proNGF in p75NTR-mediated cell 
death involved p75NTR knockout mice. ProNGF treatment of oligodendrocytes deficient 
in the receptor resulted in a significant amount of protection from proNGF-mediated 
cell death (Beattie et al., 2002).These results indicate that in order for proNGF to 
execute its death signal, it must bind to p75NTR.    
Similar to proNGF, proBDNF also exhibits high affinity binding to the p75NTR-
Sortilin complex via its prodomain to elicit cell death (H. K. Teng et al., 2005). However, 
proBDNF has also been categorized as a modulator of synaptic plasticity. The 
conversion of proBDNF to mature BDNF has been shown to promote TrkB-dependent 
long term potentiation (LTP) (Pang et al., 2004). LTP is defined as the strengthening of 
neuronal synaptic connections, and it has been established as the cellular basis of 
memory in the mammalian forebrain (Adams & Dudek, 2005). In contrast, proBDNF 
has been observed to regulate NMDA-dependent long term depression through p75NTR 
(Woo et al., 2005). LTD is the opposing process of LTP, due to it selective weakening of 
neuronal synaptic connections. The application of proBDNF to hippocampal slices 
expressing p75NTR enhanced LTD, therefore suggesting that proBDNF could act as an 
endogenous ligand to directly regulate LTD (Woo et al., 2005). Due to the expression of 
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p75NTR being developmentally regulated, it is proposed that different forms of synaptic 
plasticity may be controlled by various BDNF isoforms. Thus, proBDNF induces LTD in 
the developing hippocampus and mature BDNF induces LTP in the adult brain  (K. K. 
Teng et al., 2010).  
Although the majority of studies have focused on the biological functions of 
proNGF and proBDNF, there has been speculation that the precursors of NT-3 and 
NT-4 exhibit biological actions as well. ProNT3 has been shown to exhibit 
pro-apoptotic effects within sympathetic neurons (Yano, Torkin, Andres-Martin, V 
Chao, & K Teng, 2009) and developing spiral ganglion neurons (Jacob et al., 2011) by 
binding to the p75NTR-Sortilin high affinity complex. Additionally, proNT3 may play a 
role in responding to cellular injuries. Following barotrauma injury, proNT3 expression 
could be detected alongside p75NTR and Sortilin in spiral ganglion neurons (Jacob et al., 
2011). Furthermore, upregulation of proNT3 and p75NTR could be observed in 
photoreceptors after selective Müeller cell ablation whereas NT3 expression was 
significantly reduced (Shen, Zhu, Lee, Chung, & Gillies, 2013). Müeller cells are the 
principal glial cells of the retina and their loss or dysfunction has been linked to 
multiple retinal diseases such as macular telangiectasia type 2 and diabetic retinopathy 
(Baumann et al., 2017). The intravitreal injection of mature NT3 and p75NTR rabbit 
polyclonal antibody was able to significantly protect photoreceptors from 
degeneration (Baumann et al., 2017). Currently, there are not any reports indicating if 
proNT4 demonstrates pro-apoptotic activity or any other biological actions. However, 
the prodomain of NT4 is smaller than other neurotrophin prodomains, and it is unable 
to bind to Sortilin (Z.-Y. Chen, 2005). Therefore, NT-4 is suggested to only exist as a 
ligand for TrkB.   
1.10 Role of p75NTR in Pathology 
 As the nervous system matures, the expression of p75NTR is highly down 
regulated, with the exception of sympathetic and basal forebrain cholinergic neurons 
(Meeker & Williams, 2014). Due to this change, p75NTR was initially believed to have 
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limited function in the adult nervous system. However, p75NTR has been shown to 
modulate hippocampal synapse modifications (Woo et al., 2005) and neurogenesis 
(Bernabeu & Longo, 2010) within the adult brain. Additionally, numerous studies have 
displayed that p75NTR expression can rapidly upregulate in response to a variety of 
pathological conditions in both the central and peripheral nervous systems. For 
example, increased p75NTR expression has been observed following neuronal axotomy 
(Harrington et al., 2004), seizure (P P Roux et al., 1999; Volosin et al., 2008), ischemia 
(Kokaia, Andsberg, Martinez-Serrano, & Lindvall, 1998), and elevated intraocular 
pressure (Wei et al., 2007).  
 The induction of p75NTR reexpression during the adult life is thought to be a 
part of a process that promotes apoptosis of damaged tissues. Following seizure, the 
expression of p75NTR dramatically increased within cortical neurons subjected to 
pilocarpine-induced seizure, in which the reexpression of p75NTR correlated with 
cortical neuron cell death (P P Roux et al., 1999). Similarly, p75NTR expression was 
induced and associated with apoptosis of cholinergic neurons exposed to the 
excitotoxin, kainic acid (Oh, Chartisathian, Chase, & Butcher, 2000). Death of 
cholinergic neurons could be prevented by the function-blocking antibody, Rex, 
thereby signifying the contribution of p75NTR signaling in excitotoxin-induced death of 
within this neuronal subpopulation.  
In addition to neurons, upregulation of p75NTR has been observed in Schwann 
cells (Taniuchi, Clark, & Johnson, 1986), the cells of the peripheral nervous system 
responsible for the regeneration of damaged nerve fibers. Schwann cell migration has 
been suggested to be regulated by p75NTR due to the cells’ migration being prevented 
by the Rex antibody (Anton et al., 1994). This effect could only be observed in 
damaged sciatic nerves rather than healthy sciatic nerves, thus p75NTR may help 
regulate the movement of Schwann cells to injured areas. Intriguingly, p75NTR 
expression has also been found to increase in immune cells of the monocyctic lineage 
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(Dowling et al., 1999). However, little is known about the precise effects of p75NTR on 
cells of the immune system.  
Increased p75NTR expression has been suggested to contribute several 
neurodegenerative diseases. Over the last few decades, there have been several 
studies suggesting a link between p75NTR and Alzheimer’s disease (AD). Principally, 
p75NTR is vulnerable to the same proteolytic cleavage as amyloid precursor protein 
(APP) (K. M. Jung et al., 2003; Kanning et al., 2003), the protein from which Aβ derives. 
Both APP and p75NTR are proteolytic substrates for presenilin-1, γ-secretase, and α-
secretase. The highest levels of p75NTR expression in the adult brain are found in 
cholinergic neurons of the basal forebrain (Rabizadeh et al., 2017), which are cells 
severely damaged by AD. In AD animal models, Aβ, the main component of plaques 
found within AD patients, serves as a ligand of p75NTR capable of initiating apoptosis 
(Yaar et al., 1997). Furthermore, the brains of AD patients have been shown to express 
increased levels of proNGF (Peng, Wuu, Mufson, & Fahnestock, 2004). Remarkably, 
proNGF isolated from these brain samples induced p75NTR-mediated cell death in 
sympathetic neurons (Pedraza et al., 2005). Thus, upregulation of proNGF in AD may 
lead to p75NTR apoptotic signaling which could contribute to the neurodegeneration 
within the AD brain.  
The p75NTR has also been claimed to cause the degeneration of motor neurons 
during the progression of amyotrophic lateral sclerosis (ALS). Reexpression of the 
receptor has been detected in spinal motor neurons of an ALS mouse model as well as 
in spinal cord samples from human ALS patients. Knockdown of the receptor in ALS 
animal models has been shown to reduce neural damage as well as delay the 
progression of the disease. For example, in the superoxide dismutase 1 (SOD1) mutant 
mouse, the antisense knockdown of p75NTR resulted in a delay of ALS onset and 
progression (Turner et al., 2003).   Furthermore, extended survival of SOD1 double 
transgenic mice genetically deficient in p75NTR was observed. Although these results 
indicate p75NTR contributes to the progression of ALS, further studies are needed to 
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determine the role of p75NTR in ALS since the SOD mutation only represents a small 
population of ALS patients.  
1.11 Oxidative Stress 
Among all of the pathological conditions in which p75NTR-mediated 
degeneration has been observed, nearly all are associated with elevated reactive 
oxygen species (ROS) (Jenner Peter, 2003). The production of ROS is a natural 
incidence during mitochondrial electron transport. When produced in excess, the 
highly reactive molecules can cause a range of deleterious events. Detoxification of 
ROS is paramount to the survival of all aerobic life forms. All cells obtain a variety of 
antioxidant enzymes that are able to eradicate the harmful effects of ROS. However, if 
an imbalance occurs between excessive ROS production and the inability of 
antioxidant enzymes to detoxify the reactive species, then oxidative stress occurs.  This 
imbalance could result from limited antioxidant production or limited antioxidant 
activity.  
The term ROS collectively refers to both free radical and non-radical derivatives 
of molecular oxygen (Halliwell, 2006). The superoxide anion serves as a precursor for 
other ROS species including hydrogen peroxide, hydroxyl radical, hydroperoxyl radical, 
and nitric oxide. Superoxide anion is a product of a one-electron reduction of 
molecular oxygen and can be further reduced by one electron to yield hydrogen 
peroxide (Halliwell, 2006). Hydrogen peroxide is very unstable and it can easily diffuse 
through the plasma membrane of cells to cause cellular destruction and death (Fisher, 
2009). The mitochondrial electron transport chain is a major source of ROS production 
due to the numerous redox reactions that occur during the process. Normally, 
electrons pass through a series of electron carrier proteins to ultimately reduce 
molecular oxygen to water. However, if an electron leakage transpires, molecular 
oxygen can instead be reduced to form superoxide anion. Nevertheless, superoxide 
anion and other ROS are produced as necessary intermediates during enzymatic 
reactions (Jastroch, Divakaruni, Mookerjee, Treberg, & Brand, 2010)  
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There are various antioxidant defense mechanisms cells can utilize in order to 
control and counterattack the toxic effects of ROS accumulation. Superoxide 
dismutase (SOD) is able to catalyze the breakdown of superoxide anion to oxygen and 
hydrogen peroxide (Dasuri, Zhang, & Keller, 2013). Peroxide is then targeted and 
eliminated by peroxidase enzymes. Additionally, hydrogen peroxide can be eradicated 
by catalase, an enzyme that converts the reactive molecule to water and oxygen by 
using manganese or iron as a cofactor (Dasuri et al., 2013). In the brain, catalase is 
localized in peroxisomes (Dasuri et al., 2013). In vivo models of Alzheimer’s disease 
have shown that catalase is neuroprotective, in which impairments of the enzyme 
resulted in increased susceptibility to neuronal injury by Aβ production (Clausen, Bi, & 
Baudry, 2012; Mao et al., 2012).   
In addition, glutathione (GSH) and glutathione peroxidase (GPX) have been 
implicated to play important roles in modulating levels of oxidative stress within the 
brain (Peter Klivenyi et al., 2000; M. Lee et al., 2010). Both enzymes are part of the 
selenium-containing enzyme family, and they each mediate the removal of hydrogen 
peroxide by ultimately catalyzing the oxidant’s reduction to water (Halliwell, 2006). 
The two enzymes work together to remove hydrogen peroxide by coupling the 
reduction of hydrogen peroxide with the oxidation of GSH. This reaction forms 
oxidized glutathione (GSSG), which can be converted back to GSH by glutathione 
reductase enzymes (Halliwell, 2006). The inhibition of GSH synthesis in human glial 
cells by buthionine sulfoximine resulted in a neuroinflammatory response (M. Lee et 
al., 2010). Furthermore, when oxidative stress was induced in wild-type and GPX 
knockout mice by malonate injection, there was a significant amount of hydroxyl 
radical generation in GPX knockout mice compared to wild-type control mice (P 
Klivenyi et al., 2000). Due to these observations, GSH and GPX have been implicated as 
important hydrogen peroxide eliminators.  
The brain is highly susceptible to oxidative stress for several reasons. Firstly, 
the brain constitutes 2% of human body weight, but the organ utilizes approximately 
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20% of the body’s oxygen consumption (Dasuri et al., 2013). The primary reason for 
the high consumption of oxygen is due to the massive amounts of ATP needed to 
maintain neuronal intracellular ion homeostasis for proper action potential 
propagation and neurotransmitter secretion (Dasuri et al., 2013). Secondly, the brain is 
rich in iron due to the presence of important iron-containing proteins such as 
cytochromes, ferritin, and tyrosine hydroxylases (Dasuri et al., 2013). Therefore, ROS 
can easily be generated by way of the Fenton reaction (Kanti Das, Wati, & Fatima-Shad, 
2014). The Fenton reaction is defined as the reaction of ferrous iron (Fe2+) with 
hydrogen peroxide to produce ferric iron (Fe3+) and the highly reactive hydroxyl radical 
(Kanti Das et al., 2014).  
1.12 Dopaminergic Signaling 
Dopamine serves as an additional source of ROS production within the brain 
due to the natural production of ROS during dopamine degradation (Muñoz, 
Huenchuguala, Paris, & Segura-Aguilar, 2012). Dopamine is classified as a 
catecholamine neurotransmitter that is secreted by dopaminergic neurons and it has 
been shown to regulate a variety of functions including voluntary movement, 
addiction, memory, learning, and attention (Vogt Weisenhorn, Giesert, & Wurst, 
2016).  
Within the brain, dopaminergic neurons can be found within the 
mesencephalon (also known as the midbrain), diencephalon, and the olfactory bulbs 
(Arias-Carrián, Stamelou, Murillo-Rodríguez, Menéndez-Gonzlez, & Pöppel, 2010). 
However, the majority of all dopaminergic neurons within the central nervous system 
are located in the ventral part of the mesencephalon (ventral midbrain) (Arias-Carrián 
et al., 2010). Dopaminergic neurons within in the ventral midbrain, also known as 
mesencephalic dopaminergic neurons, can be found in three midbrain structures 
known as the substantia nigra pars compacta (SNc), the ventral tegmental area (VTA), 
and the retrorubral field (RRF) (Arias-Carrián et al., 2010). The integrity of these 
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structures is critical for proper dopaminergic signaling. For example, the degeneration 
of the substantia nigra is the ultimate cause of Parkinson’s disease.    
There are four main pathways in which dopamine transmission can undergo. 
The four pathways include the mesolimbic pathway, the mesocortical pathway, the 
tuberoinfundibular pathway, and the nigrostriatal pathway (Agid, 1991). The cell 
bodies of dopaminergic neurons of the mesolimbic pathway originate in the VTA and 
their axons project and terminate in the ventral striatum (Adinoff, 2004). This pathway 
modulates reward and pleasure. The mesocortical pathway, which regulates emotion-
related behavior, contains dopaminergic neurons that originate in the VTA and project 
to the prefrontal cortex (Arias-Carrián et al., 2010). Dopaminergic neurons of the 
tuberoinfundibular pathway originate in the arcuate nucleus of the hypothalamus and 
project to the median eminence (Weiner & Ganong, 1978). This pathway controls the 
secretion of prolactin from the anterior pituitary gland. The nigrostriatal pathway 
consists of dopaminergic neurons whose cell bodies originate in the substantia nigra 
and terminate in the dorsal striatum (Arias-Carrián et al., 2010). This pathway is 
responsible for regulating voluntary movement. The degeneration of neuronal 
projections within the nigrostriatal pathway has been shown to cause the 
characteristic tremors seen in Parkinson’s disease patients (Barbeau, 1962).  
1.13 Dopamine Metabolism 
Dopamine is synthesized in a sequential reaction within the cytosol of 
catecholaminergic neurons (Meiser, Weindl, & Hiller, 2013). First, L-tyrosine is 
hydroxylated by tyrosine hydroxylase (TH) to yield dihydroxyphenylalanine (DOPA). 
DOPA is then decarboxylated by L-amino acid decarboxylase to yield dopamine (Meiser 
et al., 2013) (Fig. 1). Upon excitation of presynaptic dopaminergic neurons; dopamine 
is released from synaptic vesicles and released into the synaptic cleft to bind to 
postsynaptic dopaminergic receptors. The physiological actions of dopamine are 
mediated by five G protein-coupled receptors (GPCRs) named D1, D2, D3, D4, and D5 
(Beaulieu & Gainetdinov, 2011). 
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Figure 1: The Dopamine Synthesis Pathway (Meiser et al., 2013) 
Dopaminergic signaling is terminated by two pathways, reuptake or  
degradation. These pathways help prevent the oxidation of dopamine to 
aminochrome, the precursor of neuromelanin and a molecule known to be neurotoxic 
(Graumann et al., 2005). Dopamine reuptake is mediated by the dopamine transporter 
(DAT), a transmembrane protein located on the presynaptic dopaminergic neuron 
(Vaughan & Foster, 2013). Molecules of dopamine are translocated from the synaptic 
cleft into the presynaptic neuron and then repackaged into synaptic vesicles by 
vesicular monoamine transporters (VMATs) (Beaulieu & Gainetdinov, 2011). VMATs 
mediate dopamine translocation into vesicles by generating a proton gradient (Muñoz 
et al., 2012). For every one molecule of dopamine taken up by VMAT, two protons are 
released. The degradation of dopamine is mediated by two enzymes, monoamine 
oxidase (MAO) and catechol-o-methyltransferase (COMT). MAO degrades excess 
dopamine by catalyzing the oxidative deamination of dopamine to 3, 4-
dihydroxyphenylacetaldehyde (DOPAL) and hydrogen peroxide (Meiser et al., 2013; 
Muñoz et al., 2012). DOPAL is then converted to 3, 4-dihydroxyphenylacetic acid 




Interestingly, both enzymes are expressed in all neurons of the central nervous 
system (Segura-Aguilar et al., 2014). MAO enzymes are localized within the outer 
membranes of mitochondria in neurons and glial cells. The two isoforms of COMT, 
soluble-COMT and membrane-bound-COMT, are found in the cell body, axons, and 
dendrites of neurons (Segura-Aguilar et al., 2014). Despite the two enzymes’ 
ubiquitous expression within various types of neurons, MAO is less prevalent in 
substantia nigral neurons and COMT is not detected at all in this neuronal 
subpopulation (Meiser et al., 2013).  
1.14 Dopamine Oxidation 
Dopamine is vulnerable to oxidation due to its electron-rich catechol moiety 
(Meiser et al., 2013). Under aerobic conditions, free cytosolic dopamine is able to 
spontaneously oxidize to dopamine o-quinones in the absence of metal catalysts 
(Meiser et al., 2013; Muñoz et al., 2012; Segura-Aguilar et al., 2014). The one-electron 
oxidation of dopamine generates dopamine o-semiquionone and one molecule of 
superoxide. Subsequently, dopamine o-semiquionone is oxidized to dopamine 
o-quionone due to the reduction of two oxygen molecules to superoxide radicals 
(Segura-Aguilar et al., 2014). Dopamine o-quinone is unstable in the cytosol at 
physiological pH, therefore the radical’s amino chain cyclizes to form aminochrome 
(Meiser et al., 2013; Muñoz et al., 2012; Segura-Aguilar et al., 2014).  
Aminochrome serves as the precursor to neuromelanin, a pigment mostly 
found within the substantia nigra (Meiser et al., 2013). Similar to melanin, 
neuromelanin is accountable for the dark color of the substantia nigra.  Studies of post 
mortem brain tissue of healthy subjects has recognized neuromelanin formation as a 
normal process that occurs over time and accumulates with age (Muñoz et al., 2012). 
Despite the pigment’s supportive role in dopamine oxidation, neuromelanin has been 
indicated to have a neuroprotective role as a metal chelator (Gerlach et al., 2003). 
However, the presence of neuromelanin supports the occurrence of dopamine 
oxidation due to the initial presence of its precursor, aminochrome.  
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Aminochrome has been reported to induce mitochondrial dysfunction by 
forming protein adducts with protein complexes I and III of the electron transport 
chain (Van Laar, Mishizen, Cascio, & Hastings, 2009). Additionally, aminochrome has 
been found to be disruptive to cytoskeleton networks in a substantia nigra-derived cell 
line by forming aggregates with α- and β-tubulin (Paris et al., 2010). Interestingly, its 
precursor, dopamine o-quinone has been reported to form adducts with a variety of 
proteins such as tyrosine hydroxylase, glutathione peroxidase, dopamine transporter, 
superoxide dismutase, and mitochondrial complexes I, III, and V. Increased levels of 
dopamine and glutathione peroxidase adducts have been detected in Parkinson’s 
disease (Spencer et al., 1998). However, due to the rapid cyclization of dopamine 
o-quinone, it is unclear if the damaging effects resulting from dopamine oxidation are 
caused by dopamine o-quinone or aminochrome (Segura-Aguilar et al., 2014).  
The oxidation of dopamine can also be catalyzed by enzymes with peroxidase 
activity such as cyclooxygenases and cytochrome p450 isoforms (Muñoz et al., 2012). 
Additionally, a variety of transition metals such as copper, iron, and manganese can 
catalyze the oxidation of dopamine (Muñoz et al., 2012). For example, the 
autooxidation and MAO-mediated degradation of dopamine generates the production 
of hydrogen peroxide, which can easily be reduced to the hydroxyl radical by way of 
the Fenton reaction (Hermida-Ameijeiras,  ndez- lvarez,   nchez-Iglesias, 
 anmart  n-Suárez, & Soto-Otero, 2004). In addition, the reaction of dopamine o-
quinone with iron can lead to the production of the neurotoxin 6-hydroxydopamine 
(6-OHDA; Fig. 2) (Napolitano, Pezzella, & Prota, 1999). 
6-OHDA is a hydroxylated analogue of dopamine (Blum et al., 2001) and is 
frequently used to model Parkinson’s disease in vitro and in vivo (Ungerstedt, 1968). 
Figure 2: 6-Hydroxydopamine (6-OHDA) Chemical Structure (Napolitano et al., 1999) 
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Due to its structural similarities to dopamine, 6-OHDA is able to travel from the cytosol 
and into the presynaptic terminal of dopaminergic neurons by way of the dopamine 
transporter (Luthman, Fredriksson, Sundström, Jonsson, & Archer, 1989). 
Consequently, the toxicity of 6-OHDA is selective for catecholaminergic neurons of 
both the central and peripheral nervous systems. In addition, the contribution of 6-
OHDA to oxidative stress is widely established. Firstly, 6-OHDA is able to auto-oxidize 
to generate hydrogen peroxide, superoxide anion, and catecholamine quinones 
(Padiglia et al., 1997). Similarly, the oxidation of 6-OHDA by MAO produces hydrogen 
peroxide, which stimulates the production of additional reactive species (Cohen, 1984). 
Furthermore, 6-OHDA has been shown to reduce the enzymatic activity of glutathione 
peroxidase and superoxide dismutase, thereby promoting neuronal damage induced 
by ROS (Perumal, Gopal, Tordzro, Cooper, & Cadet, 1992).  6-OHDA is also able to 
impair neuronal structure and metabolism by interfering with the normal functions of 
complex I of the electron transport chain (Cleeter, Cooper, & Schapira, 1992). As a 
result, the formation of superoxide radicals occurs, causing additional neuronal 
damage.  
1.15 Oxidative Stress Mediates Programmed Cell Death 
The uncontrollable accumulation of ROS within a variety of cell types has been 
found to play a vital role in mediating programmed cell death at high concentrations 
(Sinha, Das, Pal, & Sil, 2013). ROS are able to promote the release of cytochrome c by 
catalyzing the oxidation of cardiolipin, an anionic phospholipid that functions to attach 
cytochrome c to the inner mitochondrial membrane (Hirsch et al., 1997). After its 
release, cytochrome c can then interact with Apaf-1 and procaspase-9 to form the 
apoptosome, which ultimately leads to caspase activation, followed by apoptosis (Ott, 
Robertson, Gogvadze, Zhivotovsky, & Orrenius, 2002). The JNK signaling pathway is 
also regulated by oxidative stress (M. C. Wang, Bohmann, & Jasper, 2003). When 
activated, JNK signaling is able to promote programmed cell death. JNK is able to 
promote apoptosis by way of the intrinsic pathway by causing the release of 
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cytochrome c from the mitochondria (Sinha et al., 2013). The inhibition of JNK activity 
in fibroblast cells prevented cytochrome c release in response to TNF-α treatment 
(Kamata et al., 2005), thereby preventing caspase-3 cleavage and ultimately apoptosis 
from occurring. JNK is also able to indirectly activate apoptosis by activating a variety 
of transcription factors, such as c-jun, which in turn initiate the upregulation of various 
pro-apoptotic genes such as Bak, TNFα, and Fas-L (Sinha et al., 2013).  
Surprisingly, JNK has also been described as protective response that works to 
alleviate the toxic effects of ROS (M. C. Wang et al., 2003). For example, the 
introduction of a mutation in Drosophila melanogaster that augmented JNK signaling 
resulted in less oxidative damage and increase lifespan compared to wild-type flies (M. 
C. Wang et al., 2003). Additionally, the inhibition of JNK activity in human fibroblasts 
cells exposed to ultraviolet light resulted in a 30% increase in cell death compared to 
controls (Courtial et al., 2017). These results suggest that JNK activity is necessary for 
the repression of ROS accumulation. However, the association between oxidative 
stress and JNK signaling remains elusive. 
1.16 Oxidative Stress and p75NTR 
 It is widely established that Parkinson’s disease (PD) results from the 
degeneration of ventral midbrain dopaminergic neurons, also known as mesencephalic 
dopaminergic (mesDA) neurons (Vogt Weisenhorn et al., 2016). Consequently, a 
diminished amount of dopamine is released, leading to motor deficits. The underlying 
molecular mechanisms that cause the degeneration of dopaminergic neurons are 
unknown, but the progression of PD has been highly suggested to be associated with 
oxidative stress. The presence of oxidative stress in PD is supported by analyses of 
postmortem brain tissues of PD patients which have shown increased levels of protein 
carbonylation (Floor & Wetzel, 2002) as well as the DNA and RNA oxidation products 8-
hydroxy-deoxyguanosine (Alam et al., 2002) and 8-hydroxy-guanosine (J. Zhang et al., 
1999), respectively. Additionally, postmortem brain tissue from PD patients has shown 
a decreased amount of glutathione (Sian et al., 1994), a compound that functions as an 
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antioxidant molecule within the mitochondria. The link between oxidative stress and 
Parkinson’s disease is further supported by the observation that toxins such as 
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) (Sedelis, Schwarting, & Huston, 
2001), rotenone (Y. Wang et al., 2017), and 6-hydroxydopamine (6-OHDA) (Tieu, 2011) 
are capable of causing PD-like motor symptoms seen in rodents.   
Intriguingly, p75NTR has been implicated to play a role in the degeneration of 
mesencephalic dopaminergic neurons in vitro.  A variety of studies conducted by 
Simon and colleagues have indicated the homeodomain transcription factors, 
Engrailed-1 and Engrailed-2, are critical for the survival and maintenance of mesDA 
neurons during PD (Alberi, 2004; Simon, Bhatt, Gherbassi, Sgadó, & Alberí, 2006; 
 imon,  aueressig, Wurst, Goulding, & O’Leary, 2001).  In fact, Engrailed double 
mutant mice (En1-/-; En2-/-) experienced a progressive loss in mesDA neurons as well as 
PD-like motor deficiencies (Sgadò et al., 2006). Additionally, Engrailed double mutant 
mice exhibited increased expression of p75NTR within the ventral midbrain (Alavian, 
Sgadò, Alberi, Subramaniam, & Simon, 2009).  The knockdown of p75NTR expression or 
the application of a p75NTR-inhibiting antibody significantly protected Engrailed double 
mutant mesDA neurons from apoptosis (Alavian et al., 2009). These results were the 
first line of evidence suggesting p75NTR contributes to mesDA degeneration during PD. 
However, it is still unknown if p75NTR is directly responsible for causing PD-associated 
nigral neurodegeneration since double mutant Engrailed neurons are vulnerable to 
death regardless. Nonetheless, p75NTR appears to function as a stress-activated 
receptor that promotes neuronal degeneration in response to injury.  
A previous report using PC12 cells discovered that p75NTR is protective against 
oxidative stress, thereby characterizing the receptor as anti-apoptotic under oxidative 
conditions (Tyurina et al., 2005). The antioxidant capability of p75NTR was 
demonstrated to be associated with glutathione oxidation due to the increased 
amount of oxidized glutathione observed following exposure to oxidative stress 
(Tyurina et al., 2005).  These results were each observed in the presence of serum, a 
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protein-rich liquid that contains several neurotrophins that are able to bind to p75NTR. 
Therefore, each of these results was replicated in the absence of serum to determine if 
p75NTR mediates its cellular response to oxidative stress in PC12 cells in the presence 
or absence of a ligand. Remarkably, the survival rates and the amount of oxidized 
glutathione were unchanged (Tyurina et al., 2005). Thus, it was determined that p75NTR 
is able to execute its protective activity against oxidative stress in ligand-independent 
manner.  
 Investigations of sympathetic neurons have found that p75NTR is activated and 
cleaved in response to ROS (Kraemer et al., 2014). Using the lipid peroxidation product 
4-hydroxynonenal to model oxidative stress, Kraemer et al. discovered the ability of 
p75NTR to induce neuronal death and axonal fragmentation under these conditions. 
The neurodegenerative effects were attenuated in p75NTR deficient mice, thereby 
confirming the receptor’s destructive role during oxidative stress (Lotharius, 2005). 
Additionally, cleavage of p75NTR was observed to be associated with p75NTR-mediated 
neurodegeneration due to the significant protection of sympathetic neurons from 
apoptosis after TACE or DAPT pre-treatment.  Surprisingly, the neurodegenerative 
effects mediated by p75NTR were not associated with the induction of neurotrophins or 
neurotrophin binding (Kraemer et al., 2014). Blockade of the extracellular domain of 
p75NTR had no significant effect on HNE-induced neurite degeneration and apoptosis. 
Thus, p75NTR exhibited the ability to become activated and cleaved in a ligand-
independent manner under conditions of oxidative stress (Kraemer et al., 2014).   
1.17 Thesis Goals: Investigating links between Dopaminergic Neuron Degeneration 
and p75NTR  
 Although there is evidence showing oxidative stress can cause the activation 
and cleavage of p75NTR in sympathetic neurons (Kraemer et al., 2014), it is currently 
unknown if similar events occur within brain regions vulnerable to oxidative stress. The 
p75NTR has been demonstrated to contribute to cell death caused by a variety of 
cellular injuries and in neurodegenerative disease models associated with oxidative 
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stress, but the deteriorating effects of the receptor have not been clearly defined 
within the dopaminergic neuron population. Expression of p75NTR has been suggested 
to contribute to the degeneration of dopaminergic neurons of the substantia nigra 
(Alavian et al., 2009), a region of the brain that is highly degenerated by Parkinson’s 
disease. However, the direct contribution of p75NTR to dopaminergic neuron 
degeneration has not been investigated. A previous report utilizing sympathetic 
neurons demonstrated that p75NTR signaling is able to become activated by the 
catecholaminergic specific neurotoxin, 6-OHDA (Kraemer et al., 2014). This neurotoxin 
is frequently used to model oxidative stress in dopaminergic neurons to investigate the 
biochemical dysfunctions that occur in Parkinson’s disease. Therefore, my thesis 
project involved the exploration of how oxidative stress affects p75NTR signaling in 
dopaminergic neurons to better understand the underlying mechanisms that lead to 






2.1 Cell Culture  
2.1.1 LUHMES Cells 
Lund Human Mesencephalic (LUHMES) cells were purchased from ATCC 
(CRL-2927). For all experimental procedures using LUHMES cells, all cell media was 
placed in the incubator for at least 15 minutes in order for media to reach proper pH. 
T175 cell culture flasks (VWR) were pre-coated with 7 mL of poly-ornithine (50 μg/mL) 
in water at room temperature overnight. The poly-ornithine coating solution was 
removed and the flask was washed two times with water and air-dried. Next, the cell 
culture flask was coated with 5 mL of fibronectin (1 μg/mL) in PB  (1X) for 3 hours at 
37℃ in a humidified 95% air, 5% CO2 atmosphere. The fibronectin coating solution was 
removed and the flask was washed three times with water and air-dried before 
plating. Complete growth medium (19 mL) was used to allow proliferation of the 
LUH E  cells after plating. Complete growth medium consisted of Dulbecco’s 
modified Eagle’s medium/F12, N2 supplement (100x), glutamine (100x), and 40 ng/mL 
recombinant human fibroblast growth factor (R&D Systems). LUHMES cells were 
grown at 37℃ in a humidified 95% air, 5% CO2 atmosphere.  
 Proliferating LUHMES cells received a half-half exchange of complete growth 
medium every two days until they were ready for passaging. When proliferating cells 
reached 80% confluency, they were dissociated with 0.25% trypsin and then subjected 
to centrifugation (1150 RPM for 4 minutes at 23℃). Cells were then passaged onto 
poly-ornithine/fibronectin coated cell culture plates and 8-well chamber slides. 
LUHMES cells were differentiated into mature dopaminergic neurons with 
differentiating medium, which consisted of Dulbecco’s modified Eagle’s edium/F12, 
N2 supplement (100x), glutamine (100x), dibutyryl-cAMP (50X), human recombinant-
glial derived neurotrophic factor (2 ng/mL), and tetracycline (1 μg/mL). Differentiating 
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LUHMES cells received a half-half exchange of differentiating medium every two days 
until treatment.  
2.1.2 Primary Hippocampal Culture  
For primary hippocampal neuronal cultures, 8-well chamber slides were coated 
with poly-d-lysine/laminin solution (300 μL per well) overnight at room temperature. 
The next day, wells were washed with sterile water three times and then allowed to air 
dry before use. Primary hippocampal neurons were isolated from postnatal day 0 
wild-type C57BL6 pups and plated into 8-well chamber slides using Neurobasal 
medium supplemented with B-27 and glutamine. Neurons received a half-half media 
exchange every two days. On their 5th day in culture, hippocampal neurons were ready 
for cell treatment.  
2.2 Cell Treatments 
2.2.1 6-Hydroxydopamine (6-OHDA)  
6-OHDA was dissolved in phosphate-buffered saline (1X PBS) containing 0.02% 
ascorbate. Due to the high reactivity of 6-OHDA with oxygen, aliquots of 6-OHDA were 
stored at -80℃ under inert gas. Differentiated LUHMES cells were treated on their 5th 
day in culture.  
For dose-response assays, LUHMES cells were plated in 8-well chamber slides 
with complete growth medium and then differentiated with differentiating medium 
when they reached 50 to 60% confluency. For treatment, 3.5 mL of differentiating 
medium was used to treat cells with various concentrations of 6-OHDA (2.5, 5, 7.5, and 
10 μ ) for 24 hours (Figure 3). First, 600 μL of differentiating media was reserved for 
Figure 3: Visualization of 6-OHDA treatment in 8-well chamber slide 
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untreated cells. Next, 2 μL of 10 m  6-OHDA was added to 2 mL of differentiating 
medium to make 10 μ  6-OHDA. To make 5 μ  6-OHDA, 500 μL of 10 μ  6-OHDA 
was added to 500 μL of plain differentiating media. The 7.5 μ  6-OHDA solution was 
made by taking 300 μL of 10 μ  6-OHDA and combining it with 300 μL of 5 μ  6-
OHDA. To make the 2.5 μ  6-OHDA solution, 300 μL of 5μ  6-OHDA was combined 
with 300 μL of plain differentiating media. Each well contained 300 μL of its indicated 
concentrated solution. After treatment, cells were fixed with 4% paraformaldehyde 
(PFA) for 25 minutes at room temperature. Following PFA fixation, cells were rinsed 
with PBS (1X) two times at room temperature and then stored at 4℃ in 200 μL of PB  
(1X).   
For western blot analyses of p75NTR cleavage fragments, LUHMES cells were 
plated in 6-well plates with complete growth medium and then differentiated with 
differentiating medium when they reached 50 to 60% confluency. Cells were then 
treated with 6-OHDA on their 5th day of treatment. To prepare contents for 6-OHDA 
treatment, 6 mL of this media was reserved for cells that would be untreated and the 
other 6 mL of media was reserved for 6-OHDA treatment. To prepare the 10 μ  
6-OHDA solution, 6 μL of 10 m  6-OHDA was placed in 6 mL of differentiating media. 
Cells were then treated with 10 μ  6-OHDA for 12 or 18 hours. Following treatment, 
cells were lysed using a cell scraper and then triturated in 50 μL of Nonidet P-40 (NP-
40) lysis buffer supplemented with a Complete Mini EDTA-free protease inhibitor 
tablet (Roche) and PHOS-STOP (Roche). To extract protein from the cell lysates, 
sonication was conducted, followed by protein clarification using a centrifuge (12,000 
RPM for 10 minutes at 4℃). Lysates were then stored at -80℃.  
For assessment of neurotrophin involvement in 6-OHDA induced apoptosis, 
neurons were pretreated with 9650 immune serum containing ligand-blocking 
antibody specific for the p75NTR extracellular domain (α-p75NTR ECD, 1:500) for 45 
minutes. Neurons were then exposed to 5 or 10 μ  6-OHDA for 24 hours followed by 
PFA fixation. For western blot analyses of neurotrophin involvement in the induction 
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of p75NTR cleavage following 6-OHDA treatment, neurons were pretreated with the 
9650 antibody for 45 minutes and then treated with 10 μ  6-OHDA for 12 hours.  
2.2.2 4-Hydroxynonenal (HNE) 
 HNE was dissolved in absolute ethanol (200 proof) to create three aliquots of 
5mM stock solution and one aliquot of 0.5mM stock solution. Hippocampal neurons 
were treated with various concentrations of HNE (vehicle, 0.5, 1, 5, 10, 15 μ ) for 24 
hours (Figure 4). Vehicle solution was prepared by adding 2 μL of absolute ethanol to 
0.5 mL of plating media. To prepare the 0.5 μ  solution of HNE, 1 μL of 0.5m  HNE 
was added to 1 mL of plating media. To prepare the 1 μ  HNE solution, 1 μL of 0.5 
m  HNE was added to 0.5 mL of plating media. To prepare the 5 μ  HNE solution, 1 
μL of 5 m  HNE was added to 1 mL of plating media. The 10 μ  HNE solution was 
prepared by adding 1 μL of 5 m  HNE to 0.5 mL of plating media. The 20 μ  HNE 
solution was prepared by adding 2 μL of 5 m  HNE to 0.5 mL of plating media. Each 
well contained 300 μL of treated solution.  
2.3 Western Blot Analyses 
 Total protein of LUHMES cell lysates was quantified by the Bradford assay. The 
Bradford assay was conducted by first placing 200 μL of Bradford solution (1X) in 
columns 1 through 6 and rows A through C of a 96-well plate. A new pipette tip was 
used for each column. Next, 1 μL of NP-40 was mixed in each row of column 1. This 
column was designated as the “blank.”  ubsequently, various volumes of Bovine 
Serum Albumin (BSA; 2mg/mL) were placed into each column of the 96-well plate 




(Figure 5). Column 7 was used to mix 1 μL of the ‘Untreated’ cell lysate. Column 8 was 
used to mix 1 μL of ‘10 μ  6-OHDA’.  The Bradford assay was then placed in a 
microplate reader to calculate the absorbance of each sample at 595 nm. The 
absorbance values of each column were averaged together and then used to generate 
a standard curve with the dependent variable (BSA mg/mL) on the X-axis and the 
independent variable (absorbance) on the Y-axis. A linear equation was then 
generated using Excel and the protein concentration for each cell lysate was calculated 
by solving for X.  
LUH E  protein samples (40 μg) were prepared in Laemmli sample buffer (6X) 
and boiled for 10 minutes at 98℃.  Samples were then loaded into a 15% acrylamide 
gradient gel and separated by SDS PAGE using 5X running buffer at 150 millivolts. After 
successful protein separation, protein was then transferred to a PVDF membrane using 
the standard wet transfer method for 18 hours at 111 milliamps. After transfer 
completion, membranes were blocked in 5% dry milk dissolved in 0.1% Tween-PBS 
(PBS-T), followed by overnight incubation with primary p75NTR ICD anti-serum (1:3000) 
at 4℃. Subsequently, membranes were washed of primary antibody multiple times 
Figure 5: Bradford Assay (volume of BSA per well) 
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with PBS-T, and then incubated with secondary anti-rabbit horseradish peroxidase 
(HRP)-conjugated antibody (1:10,000) at room temperature for 2 hours. Once 
secondary incubation was complete, membranes were washed and developed using 
ECL for visualization of the p75NTR full length receptor FEMTO was used to visualize the 
p75NTR C-terminal fragment and the p75NTR intracellular domain. Image acquisition was 
conducted using the Bio-Rad ChemiDoc MP System. To assess equal gel loading among 
protein samples, Actin was used as a loading control. Blots were stripped for 12 
minutes using stripping buffer and then washed 8 times with PBS-T. Blots were then 
blocked in 5% milk for 1 hour and then incubated with Actin (1:1000) overnight at 4℃. 
Following primary antibody incubation, blots were then washed several times with 
PBS-T and then incubated with secondary anti-mouse HRP antibody (1:5000) for 2 
hours. ECL was used to for Actin visualization. For assessment of ERK proteins (1:1000), 
protein samples were loaded into 10% acrylamide gradient gels and then incubated in 
secondary anti-rabbit HRP antibody (1:10,000) for visualization with ECL. Actin was 
also used as a loading control for ERK blots.  
2.4 Quantification of Neuronal Cell Death  
 Following 6-OHDA treatment, LUHMES cells in 8-well chamber slides were fixed 
with 4% paraformaldehyde for 25 minutes at room temperature. Cells were then 
washed of PFA two times with PBS (1X). In order for immunostaining antibodies to 
successfully bind to their targets, cells were permeabilized with 0.1% Triton-PCS for 30 
minutes and then washed three times with PBs (1X). Next, cells were incubated in 
blocking solution (10% normal goat serum diluted in 0.1% Triton-PBS) for one hour at 
room temperature. Subsequently, cells were incubated with the neuron-specific β-III 
tubulin antibody, TUJ1 (1:1000), overnight at 4℃. After primary incubation, slides were 
washed three times with 0.1% Triton-PBS and then two times with PBS (1X). Cells were 
then incubated with the rabbit anti-mouse Alexa Fluor 568 secondary antibody 
(1:1000) for 2 hours at room temperature. The secondary antibody was washed 7 
times with PBS (1X) followed by nuclei labeling with the nucleic acid stain 
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4’,6-Diamidino-2-Phenlindole (DAPI; 5 μg/μL) for 5 minutes. DAPI was then washed off 
with PBS (1X) three times. The 8-well chamber slides were then prepared for coverslip 
mounting by removing the chambers of the 8-well using a Chamber removal tool. Once 
the chambers were removed, slides were then mounted with a coverslip using 
Permount. Permount was allowed to dry overnight to ensure the coverslip was 
strongly adhered to the slide. Nuclei were blindly scored as apoptotic or non-apoptotic 
based on the appearance of nuclei being condensed or fragmented. Confocal images 
were collected on a ZEISS LSM 800 laser scanning confocal microscope using a 40X 
objective.  
2.5 Statistical Analyses 
 All data were expressed as the mean ± standard error means (SEM). Statistical 
comparisons between the p75NTR cleavage fragments of 6-OHDA treated and 
untreated LUH E  neurons were performed using the  tudent’s t-test. Statistical 




EVALUATING PROTEOLYSIS OF P75NTR WITHIN DOPAMINERGIC NEURONS SUBJECTED 
TO OXIDATIVE STRESS 
3.1 Introduction 
 Despite the variety of ligands, co-receptors, and adaptor proteins that have 
been reported to activate p75NTR-mediated signaling pathways, the precise molecular 
mechanisms to which p75NTR signaling becomes activated remains poorly understood. 
However, the regulated intramembrane proteolysis of p75NTR has been firmly 
established among all p75NTR signaling mechanisms. During this process, the 
extracellular domain of p75NTR is cleaved by the mellatoprotease TNF-α converting 
enzyme (TACE), leaving the remaining portion of the membrane-bound receptor, the 
C-terminal fragment (CTF), vulnerable to a second proteolytic cleavage. The 
γ-secretase complex further cleaves the CTF within its transmembrane region, thereby 
releasing the intracellular domain (ICD) of p75NTR. These cleavage events have been 
demonstrated to promote the activation of various signaling pathways and cellular 
physiological responses such as c-jun N-terminal kinase (JNK) activation (Kenchappa et 
al., 2010), nuclear translocation of neurotrophin receptor interacting-factor (NRIF) 
(Volosin et al., 2008), apoptosis (Friedman, 2000; Kenchappa et al., 2006; Kraemer et 
al., 2014), cell cycle arrest (Ceni et al., 2010), and Trk-mediated activation of survival 
signaling pathways (Ceni et al., 2010; Kommaddi, Thomas, Ceni, Daigneault, & Barker, 
2011b). The proteolytic cleavage of p75NTR has been demonstrated to occur in 
sympathetic neurons exposed to the lipid peroxidation product, 4-hydroxynonenal 
(HNE). These events were shown to occur in a ligand-independent manner, indicating 
the role of p75NTR in sympathetic neuron degeneration is novel. However, it is 
unknown if similar events occur in dopaminergic neurons.  
Primary cultures of midbrain neurons comprise a mixture of different cell 
populations, in which only 1% of those populations are dopaminergic neurons. This 
small population percentage is unsuitable for analysis of proteins by western blot 
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analysis. Therefore, our studies utilized the Lund Human Mesencephalic (LUHMES) cell 
line, a conditionally-immortalized human midbrain cell line, attributable to their 
expression of a tetracycline-responsive v-myc gene that can be differentiated into 
mature dopaminergic neurons (Lotharius, 2005).  Within several days of incubation in 
cell culture medium containing tetracycline, cyclic-AMP (cAMP), and glial derived 
neurotrophic factor (GDNF), LUHMES cells can be fully differentiated into mature 
dopaminergic-like neurons. The dopaminergic neuron-related features of 
differentiated LUHMES cells have been confirmed by their expression of dopaminergic 
biomarkers including tyrosine hydroxylase and dopamine transporter (X. M. Zhang, Yin, 
& Zhang, 2014). Cytotoxicity has been observed within the LUHMES cell culture system 
after treatment with MPP+, a dopaminergic neuron specific toxin known to be uptaken 
by the dopamine transporter to induce its toxic effects (X. M. Zhang et al., 2014). 
Similar to human dopaminergic neurons, LUHMES cells are able to release and uptake 
dopamine as well as conduct action potentials (Scholz et al., 2011).  
The physiological relevance, large culture scale, and homogenous population of 
LUHMES cells make them an efficient model for studying the effects of degenerating 
dopaminergic neurons. Furthermore, the cell line is human-derived, thereby making 
degenerative effects more relevant to human neurodegenerative diseases. Therefore, 
our investigations have utilized the LUHMES cell line. In this study, we exposed 
LUHMES cells to 6-OHDA, a neurotoxin used to model oxidative stress, in order to 
assess if p75NTR proteolysis occurs under these conditions. 6-OHDA is dopaminergic 
specific due to its ability to enter dopaminergic neurons via the dopamine transporter 
(Luthman et al., 1989). Once inside, 6-OHDA has been shown to deplete proteasome 
activity (Elkon, Melamed, & Offen, 2004), activate cell death pathways by causing 
caspase-3 elevation (Hanrott, Gudmunsen, O’Neill, & Wonnacott, 2006), and interfere 
with normal mitochondrial function by impairing protein complexes of the electron 
transport chain (Cleeter et al., 1992). The auto-oxidation of 6-OHDA has been shown to 
promote the generation of various reactive oxygen species such as hydrogen peroxide, 
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superoxide anion, hydroxyl radicals, and quinones (Hanrott et al., 2006). Furthermore, 
hydrogen peroxide has been implicated as a key mediator of 6-OHDA-induced cell 
death due to the attenuation of catalase activity which led to a significant amount of 
protection of PC12 cells from 6-OHDA-induced cell death (Hanrott et al., 2006).  
In order to understand the pathogenicity of neurodegenerative conditions such 
as Parkinson’s disease, scientific investigations must identify the triggers and 
mechanisms that are involved in the progression of the disease. By understanding how 
Parkinson’s disease begins, therapeutic treatments can successfully slow or stop 
neurodegeneration from occurring. There are a wide range of cellular models that 
have been used to study Parkinson’s disease such as toxin-based models and genetic 
models (Potashkin, Blume, & Runkle, 2011). Ideally, a model of Parkinson’s disease 
should allow the characteristic of Parkinson’s disease progression to occur in order to 
assess the onset of neurodegeneration. This is one reason why genetic models of 
Parkinson’s disease, such as the Engrailed deficient model, are useful because they 
provide the opportunity to intervene with the progression of neurodegeneration 
(Potashkin et al., 2011). In contrast, toxin-based models, such as 6-OHDA, induce 
immediate neurodegeneration, thereby preventing assessment of neurodegeneration 
progression (Potashkin et al., 2011). However, numerous reports have showed that 6-
OHDA toxicity is able to induce molecular alterations that are similar to those seen in 
Parkinson’s disease (Potashkin et al., 2011). Therefore the 6-OHDA-induced model of 
Parkinson’s disease is beneficial to explore the mechanisms of neurodegeneration in 
Parkinson’s disease.  
Due to a previous report showing that p75NTR is able to become activated and 
cleaved in response to oxidative stress, as well as mediate the degeneration of 
sympathetic neurons exposed to oxidative stress, these results provide evidence that 
there may be a link between p75NTR signaling and oxidative stress. Furthermore, these 
results suggest that p75NTR signaling could be one mechanism by which 
neurodegeneration occurs in sympathetic neurons exposed to oxidative stress. These 
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findings discovered by Kraemer et al. enhance the understanding of how p75NTR 
signaling can be activated as well as how the receptor may contribute to the etiology 
of neurodegenerative conditions. Whether p75NTR can become activated by oxidative 
stress in dopaminergic neurons is unknown. By using 6-OHDA to induce a 
well-established model of oxidative stress in dopaminergic neurons, a better 
understanding of p75NTR signaling in the brain will be achieved. 
3.2 Experimental Procedures 
3.2.1 Cell Culture 
 Please refer to Chapter 2, section 2.1, for information regarding cell culture 
procedures. 
3.2.2 Cell Treatments 
 Please refer to Chapter 2, section 2.2, for information regarding cell treatment 
procedures.   
3.2.3 Western Blot Analyses 
 Please refer to Chapter 2, section 2.3, for information regarding Western blot 
analyses.  
3.2.4 Quantification of Neuronal Death  
 Please refer to Chapter 2, section 2.4, for information regarding quantification 
of neuronal death.  
3.3 Results 
3.3.1 Cleavage of p75NTR is stimulated by 6-OHDA 
 The 6-OHDA neurotoxin is commonly used to induce degeneration of 
dopaminergic neurons in order to investigate motor and biochemical dysfunctions that 
occur in Parkinson’s disease. To examine the effect of 6-OHDA on the viability of our 
culture system, LUHMES neurons were treated with a range of 6-OHDA concentrations 
for 24 hours and then blindly scored for death based on nuclear morphology. 6-OHDA 
induced death of differentiated LUHMES cells in a dose-dependent manner, with 10 




Figure 6: 6-OHDA Promotes Dose-Dependent Apoptosis of Differentiated LUHMES 
Neurons. A; Confocal images of differentiated LUHMES cells treated with the indicated 
concentrations of 6-OHDA for 24 hours. Neurons were stained for the neuronal marker 
ß-III tubulin (displayed in green). Nuclei were labeled with the nucleic acid stain 4', 6-
Diamidino-2-Phenylindole (DAPI) (displayed in blue) and scored as apoptotic or 
non-apoptotic. B; Quantification of apoptosis induced by various concentrations of 
6-OHDA (n=6 for each treatment group). An increased percentage of apoptosis was 
observed as the concentration of 6-OHDA increased. Results are expressed as the mean 





Using the maximally effective dose of 6-OHDA (10 μ ), we investigated 
whether 6-OHDA is able to stimulate proteolytic cleavage of p75NTR.  LUHMES cells 
were treated with 10 μ  6-OHDA for 12 or 18 hours and then subjected to Western 
blot analysis using an antibody specific for the intracellular domain of p75NTR (1:3000). 
Cleavage of p75NTR could be observed after 12 hours (Figure 7) in which there was a 
significant difference between the treated and untreated p75NTR full-length receptor 





However, cleavage fragments were more apparent in LUHMES neurons treated with 
6-OHDA for 18 hours (Figure 8). Interestingly, the total expression level of p75NTR,  
represented by the 75-kDa molecular weight marker, appeared to decrease in 
response to 6-OHDA treatment. This result suggests that 6-OHDA treatment causes the 
full-length receptor to become down regulated due to the increase in cleavage activity 
by the mellatoproteinases, TACE and γ-secretase. Thus, 6-OHDA stimulates the 
proteolytic cleavage of p75NTR. 
Figure 7: 6-OHDA Promotes Proteolytic Cleavage of p75NTR after 12 hours: A; 
Differentiated LUHMES cells were treated on their 5th day of differentiation with 10 
μM of 6-OHDA for 12 hours (n=5). Cells were then subjected to lysis and western blot 
analysis using an antibody specific for the intracellular domain of p75NTR. FL, full 
length; CTF, C-terminal fragment; ICD, intracellular domain. B; Quantification of p75NTR 
fragments following 10 μM 6-OHDA treatment for 12 hours (n=5 independent 
experiments conducted). Results are expressed as the mean ± S.E.M.  tudent’s t-test 
(FL data; significant; p=0.0194) (CTF data; not significant; p=0.1355) (ICD data; 





Figure 8: 6-OHDA Promotes Proteolytic Cleavage of p75NTR after 18 hours:                  
A; Differentiated LUHMES cells were treated with 10 μM 6-OHDA for 18 hours (n=5 
independent experiments conducted). Cells were then subjected to lysis and western 
blot analysis using an antibody specific for the intracellular domain of p75NTR. FL, full 
length; CTF, C-terminal fragment; ICD, intracellular domain. B; Quantification of p75NTR 
fragments following 10 μM 6-OHDA treatment for 12 hours (n=5). Results are 
expressed as the mean ± S.E.M. (FL data; not significant; p=0.0588) (CTF data; 





3.3.2 Ligand-Mediated Activation of P75NTR is not Required for Proteolytic Cleavage or 
Apoptosis Induction  
Due to the ligand-independent mechanism at which p75NTR becomes cleaved in 
sympathetic neurons subjected to oxidative stress, we investigated whether similar 
events occurred in dopaminergic neurons exposed to 6-OHDA. Neurons were 
pre-treated with the 9650 immune serum containing ligand-blocking antibody specific 
for the extracellular domain of p75NTR (α-p75NTR ECD) for 45 minutes, followed by 
exposure to 6-OHDA (10 μ ) for 12 hours. Cells were then subjected to Western blot 
analyses using an antibody specific for the p75NTR ICD. Surprisingly, proteolytic 
cleavage of p75NTR was able to occur regardless of ligand binding (Figure 9).  
Proteolytic cleavage of p75NTR has been implicated to contribute to cell death in 
sympathetic(Kenchappa et al., 2006; Kraemer et al., 2014) and hippocampal neurons 
(Friedman, 2000). Within these cell types, inhibition of p75NTR cleavage using TACE and 
γ-secretase inhibitors significantly protected neurons from apoptosis. Due to the 
ability of p75NTR still being able to undergo proteolytic cleavage in the absence of 
ligand binding, we next wanted to see if blocking the ligand-binding domain of p75NTR 
Figure 9: 6-OHDA induces p75NTRproteolytic cleavage in a ligand-independent 
mechanism: LUHMES neurons were pre-treated with ligand-blocking α-p75NTR ECD 
antibody for 45 minutes and then exposed to 6-OHDA (10 μM) for 12 hours (n=1 
independent experiment conducted). Neurons were then subjected to Western blot 
analysis using an antibody specific for the p75NTR ICD.    
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could protect cells from the toxic effects of 6-OHDA. Neurons plated into 8-well 
chamber slides were pre-treated with α-p75NTR ECD for 45 minutes, followed by 5 μ  
6-OHDA treatment for 24 hours. Remarkably, inhibition of the extracellular domain of 
p75NTR failed to significantly protect neurons from 6-OHDA-induced death (Figure 10). 
Collectively, these data suggest that oxidative stress promotes p75NTR-mediated 





Figure 10: Treatment of differentiated LUHMES neurons with 9650 ligand-
blocking α-p75 ECD antibody protects LUHMES cells from 6-OHDA-induced 
death: A; Confocal images of LUHMES cells exposed to 5μM 6-OHDA for 24 
hours following a 45 minute pretreatment with immune serum containing a 
ligand blocking antibody specific for the extracellular domain of p75NTR.   
Neurons were stained for the neuronal marker, ßIII-tubulin (red). Nuclei were 
labeled with DAPI stain and scored as apoptotic (indicated by arrowheads) or 
non-apoptotic. A reduction in apoptosis was observed in cells pre-treated with 
the ligand-blocking antibody compared to cells lacking pretreatment.  B; 
Quantification of apoptosis induced by 6-OHDA after a 45 minute pretreatment 
with immune serum containing a ligand blocking antibody specific for the 
extracellular domain of p75NTR (n=4 for each treatment group). Pretreatment 
with the ligand-blocking antibody caused a substantial reduction in apoptosis 











3.3.3 6-OHDA Suppresses ERK Activity   
 An investigation conducted by Alvian and Simon et al. showed that ERK 
phosphorylation could be detected within wild-type mesDA neurons but not in double 
mutant Engrailed neurons, which contain elevated levels of p75NTR expression175. 
These results led our lab to investigate whether oxidative stress is able to suppress the 
phosphorylation of ERK. LUHMES cells were treated with 6-OHDA (10 μ ) for 18 hours 
and then subjected to cell lysis for western blot analyses. Remarkably, there was a 
suppression of ERK phosphorylation following 6-OHDA treatment despite equal levels 
of total ERK protein (Figure 11).  
  
Figure 11: Oxidative stress does not induce ERK-1/2 Activation in LUHMES 
neurons. Representative Western blot of ERK-1/2 phosphorylation in untreated 




3.3.4 HNE Causes Dose-Dependent Death of Hippocampal Neurons 
In addition to our experiments utilizing dopaminergic neurons, our lab also 
began exploring the effect of oxidative stress on hippocampal neurons, another 
population of cells that are located within a region of the brain that is highly 
degenerated by Alzheimer’s disease. To mimic oxidative stress in hippocampal 
neurons, our lab used the lipid peroxidation product 4-hydroxynonenal (HNE) due to 
its wide recognition as a key mediator of neuronal apoptosis induced by oxidative 
stress. We observed that HNE was able to cause death of hippocampal neurons in a 
dose-dependent manner (Figure 12). Furthermore, we noticed that the 20 μM 






































Figure 12: HNE Promotes Dose-Dependent Apoptosis of Hippocampal Neurons. 
A; Fluorescent microscope images of hippocampal neurons treated with the 
indicated concentrations of HNE for 24 hours. Neurons were stained for the 
neuronal marker ß-III tubulin (displayed in green). Nuclei were labeled with the 
nucleic acid stain 4', 6-Diamidino-2-Phenylindole (DAPI) (displayed in blue) and 
scored as apoptotic or non-apoptotic. B; Quantification of apoptosis induced by 
various concentrations of HNE (n=1 for each treatment group). An increased 
percentage of apoptosis was observed as the concentration of 6-OHDA 




3.4 Discussion  
 The role of p75NTR as an apoptotic mediator in response to oxidative stress has 
been established in sympathetic neurons (Kraemer et al., 2014). The lipid peroxidation 
product, HNE, has been demonstrated to induce p75NTR-mediated apoptosis and 
axonal degeneration of sympathetic neurons. Neurons lacking the receptor were 
significantly protected from HNE-induced axonal degeneration and apoptosis, thereby 
suggesting p75NTR as a regulator of neuronal responses to oxidative stress. Here, we 
demonstrate that p75NTR is expressed in fully differentiated LUHMES cells exposed to 
6-OHDA neurotoxicity. Therefore, p75NTR may regulate responses to oxidative stress in 
dopaminergic neurons as well. 
The expression of p75NTR is ubiquitous during embryonic development; 
however, numerous investigations have demonstrated that reexpression of the 
receptor during adulthood is associated with various cellular injuries and 
neurodegenerative conditions, leading to cell death. Reexpression of p75NTR has been 
observed to occur in response to seizures (P P Roux et al., 1999; Volosin et al., 2008), 
ischemia (Kokaia et al., 1998), neuronal axotomy (Harrington et al., 2004), as well as 
within models of Alzheimer’s disease (Murphy et al., 2015) and Amyotrophic sclerosis 
(Lowry et al., 2001; Turner et al., 2004), conditions highly associated with oxidative 
stress. It is currently unknown why reexpression of p75NTR expression occurs in 
response to various injuries, but a few hypotheses have been made suggesting the 
receptor may promote positive effects following injuries. For instance, the expression 
of p75NTR has been previously demonstrated to increase following axonal injury and 
induce apoptosis(Harrington et al., 2004). However, there have been reports that 
p75NTR signaling is able to promote remyelination of injured sciatic nerves. Adult mice 
deficient in p75NTR experienced a reduction in the number of myelinated axons 
following sciatic nerve lesion compared to wild-type controls (Song, Zhou, Zhong, Wu, 
& Zhou, 2006). Furthermore, the transplantation of p75NTR deficient Schwann cells in 
mice resulted in a significant impairment in motor neuron recovery following sciatic 
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nerve injury (Tomita et al., 2007). The p75NTR deficient Schwann cells failed to promote 
remyelination, axonal regrowth, and radial growth in axon calibers compared to 
wild-type controls (Tomita et al., 2007). Therefore, the receptor might initiate 
apoptosis in injured sciatic nerves in order to provide a more suitable environment for 
remyelination.  
The pro-apoptotic role of p75NTR has also been suggested to control 
inflammation by encouraging the elimination of damaged cells. For example, the 
induction of encephalomyelitis (EAE) in has been demonstrated to cause an 
upregulation of p75NTR in endothelial cells, leading to cell death (Copray et al., 2004). 
However, when EAE was induced in mice deficient for p75NTR, the mice developed 
increased levels of inflammation within the central nervous system compared to 
wild-type controls (Copray et al., 2004). It is widely established that without 
inflammatory control, widespread tissue damage can contribute to the pathogenesis 
of numerous diseases (Rock & Kono, 2008). Therefore the detrimental effects of p75NTR 
may be a part of a homeostatic mechanism that goes out of control. Supportive 
evidence of this theory includes a study conducted by Miller and colleagues (Park, 
Grosso, Aubert, Kaplan, & Miller, 2010) demonstrating that p75NTR regulates the 
specificity of neural connectivity in basal forebrain axons by inducing axonal 
degeneration.  
The mechanism of p75NTR proteolytic cleavage is well-established, but its 
functional significance has not been fully elucidated. Pharmacological investigations 
have demonstrated that p75NTR proteolytic cleavage relates to the induction of cell 
death in hippocampal (Kenchappa et al., 2006) and sympathetic neurons (Volosin et al., 
2008) after seizure and proBDNF treatment, respectively. Likewise, p75NTR cleavage 
was detected in sympathetic neurons subjected to oxidative stress, which 
corresponded with neuronal apoptosis and degeneration. The induction of p75NTR 
cleavage has been observed in sympathetic neurons following HNE and 6-OHDA 
treatment, indicating multiple oxidants are able to initiate p75NTR signaling 
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mechanisms within these cells. Although p75NTR activation could be observed in 
response to oxidative stress in sympathetic neurons, further investigations are needed 
to determine if p75NTR can be similarly activated by oxidative stress in neurons of the 
brain, especially in brain regions vulnerable to oxidative stress such as the ventral 
midbrain. Furthermore, investigating whether p75NTR contributes to the degeneration 
of neurons in the ventral midbrain could provide insight that the receptor is linked to 
oxidative stress-associated disorders such as Parkinson’s disease. Due to the 
abundance of studies reporting 6-OHDA induces oxidative stress and apoptosis in 
dopaminergic neurons, we wanted to investigate if 6-OHDA is able to stimulate 
proteolysis of p75NTR within the dopaminergic neuron population.  
The ventral midbrain contains a basal ganglia structure known as the substantia 
nigra which is highly degenerated by Parkinson’s disease, a neurodegenerative 
condition associated with oxidative stress. The utilization of the LUHMES culture 
system, an immortalized human mesencephalic cell line that can be differentiated to 
mature dopaminergic neurons, allowed us to investigate the effects of oxidative stress 
on p75NTR proteolytic cleavage and dopaminergic neuron viability.  Our results 
demonstrated p75NTR undergoes proteolysis in response to 6-OHDA treatment within 
the LUHMES cell culture system. The cleavage fragments of 6-OHDA treated LUHMES 
cells were noticeably prominent compared to untreated cells, which was similar to the 
results of sympathetic neurons treated with HNE. Our assessment of p75NTR proteolysis 
was conducted by exposing dopaminergic neurons to 6-OHDA treatment for 12 hours, 
which was consistent with previous treatment times utilizing sympathetic neurons 
treated with HNE. Proteolytic cleavage of p75NTR in sympathetic neurons was 
characterized as an event that needed to occur prior to the induction of programmed 
cell death. Inhibition of p75NTR cleavage by TACE inhibitors significantly protected 
sympathetic neurons from HNE-induced apoptosis (Kraemer et al., 2014). Due to the 
similarities in CTF and ICD in dopaminergic neurons and sympathetic neurons following 
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12 hour exposure to oxidative stress, we hypothesize that p75NTR proteolysis will be 
the initiating event of 6-OHDA-induced cell death in dopaminergic neurons.  
Both p75NTR cleavage fragments have been described as necessary components 
for p75NTR-mediated cell death, but there is much controversy on which fragment is 
actually the main regulatory component of p75NTR-mediated cell death. Coulson and 
colleagues propose the CTF is primarily responsible for the death inducing abilities of 
p75NTR due to the presence of a 29 amino acid sequence in the p75NTR CTF 
juxtamembrane membrane region, known as the “chopper domain”(E J Coulson et al., 
2000). On the other hand, the p75NTR ICD has been heavily suspected as a critical 
regulator of p75NTR-mediated apoptosis due to its expression of a “death domain,” as 
well as its ability to interact with adaptor proteins that regulate apoptotic signaling, 
such as TRAF6, NRIF, NRAGE, NADE, and MAGE homologs. Our dose response assays 
showed that the maximally effective dose of 6-OHDA (10 μ ) caused almost 100 
percent cell death. In analyses of p75NTR cleavage, the maximally effective dose of 6-
OHDA induced an abundant expression of p75NTR ICD compared to p75NTR CTF in 
dopaminergic neurons. Furthermore, a reasonable amount of CTF expression could still 
be detected in untreated cells, thereby suggesting p75NTR undergoes low basal rates of 
TACE cleavage. We speculate 6-OHDA has a marked effect on γ-secretase cleavage 
compared to TACE cleavage. Inhibition of γ-secretase cleavage has previously been 
shown to prevent p75NTR-mediated apoptosis (Kenchappa et al., 2006).  ince γ-
secretase cleavage leads the generation of the p75NTR ICD, we also speculate that the 
p75NTR ICD may have a critical role in mediating dopaminergic neuron death in 
response to oxidative insult compared to the p75NTR CTF. However, further 
investigations are needed to examine the downstream effects of p75NTR cleavage in 
dopaminergic neurons.  
Interestingly, total expression of p75NTR full length (represented by band at the 
75 kDa weight marker) decreased in 6-OHDA treated cells compared to untreated cells. 
Our results contrasted with those of numerous investigations indicating that 
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expression of p75NTR is upregulated following several injuries. The expression of p75NTR 
has been shown to upregulate in a time-dependent manner following axotomy 
(Harrington et al., 2004), spinal cord injury (Beattie et al., 2002), seizure (P P Roux et 
al., 1999), and kainic acid toxicity (Y.-Q. Wang, Bian, Bai, Cao, & Chen, 2008). However, 
the expression of p75NTR peaked several days after injury (Beattie et al., 2002; 
Harrington et al., 2004; P P Roux et al., 1999) or until neurons could no longer undergo 
cell death (Harrington et al., 2004). In our experiments, downregulation of p75NTR full 
length receptor could be observed following 12 hours of treatment with the 6-OHDA 
maximally effective dose. Relative to prior research (Harrington et al., 2004), these 
results may indicate that after 12 hours of 6-OHDA treatment, LUHMES neurons are 
unable to undergo cell death any further, thereby initiating downregulation of p75NTR. 
We currently have not assessed expression of the receptor prior to 12 hours of 
6-OHDA treatment, therefore it is possible p75NTR expression could be upregulated 
before then. Increased expression of p75NTR could be detected in dopaminergic 
neurons after 30 minutes of exposure to kainic acid, so it is likely p75NTR initiates an 
immediate and rapid response in these cells following injury. However, further 
investigations are needed to understand the contribution of p75NTR signaling to the 
degeneration of dopaminergic neurons.   
Transgenic mouse models have revealed that the transcription factors 
Engrailed-1/Engrailed-2 (collectively called Engrailed or En1/2), are critical for the 
survival and maintenance of mesDA neurons during late embryonic life (Rekaik, 
Blaudin de Thé, Prochiantz, Fuchs, & Joshi, 2015). Engrailed double mutant (En1-/-; 
En2-/-) mesDA neurons have been observed to die by apoptosis during the stage when 
the induction of Engrailed expression begins (Alberi, 2004; Simon et al., 2001). 
Remarkably, immunohistochemistry experiments revealed Engrailed deficient mesDA 
neurons exhibit elevated levels of p75NTR along with caspase-3 and caspase-9 
activation (Alavian et al., 2009). These results suggest if p75NTR contributes to the 
death of Engrailed deficient neurons then the receptor must do so by way of the 
65 
 
intrinsic apoptotic signaling cascade. Similarly, 6-OHDA treatment of Engrailed 
heterozygous mice induced caspase-9 activation (Alavian et al., 2009). Relative to our 
investigations, these results suggest that the intrinsic apoptotic signaling cascade is 
responsible for killing LUHMES neurons exposed to oxidative stress. Furthermore, 
previous investigations have shown that the intrinsic apoptotic signaling cascade is a 
downstream signaling pathway of p75NTR due to the significant protection of 
hippocampal neurons from programmed cell death following Apaf-1 and caspase-9 
downregulation (Troy et al., 2002). Therefore, it is possible p75NTR mediates the death 
of LUHMES neurons through the intrinsic death pathway following 6-OHDA treatment. 
However, further research is needed to clarify the apoptotic signaling cascade that is 
mediated by p75NTR in these cells.    
Previous investigations have shown that p75NTR is able to augment Trk 
signaling107, 192 thereby promoting cellular survival. The coexpression of p75NTR with 
TrkA in PC12 cells was shown to delay the internalization and degradation of TrkA 
thereby prolonging TrkA signaling events due to TrkA being able to remain on the 
cellular surface following neurotrophin binding (Makkerh et al., 2005). Furthermore, 
Barker and colleagues have demonstrated that Trk receptors are able to promote 
proteolytic cleavage of p75NTR following neurotrophin binding, further leading to the 
phosphorylation of the Akt and ERK proteins following generation of the p75NTR ICD by 
γ-secretase (Ceni et al., 2010). However, high expression of p75NTR has been shown to 
suppress the phosphorylation of ERK in double mutant Engrailed mesDA neurons 
(Alavian et al., 2009). Double mutant Engrailed neurons have been shown to express 
high levels of p75NTR that correlate with the induction of cell death. Additionally, these 
neurons exhibited a suppression of ERK activity compared to wild-type mesDA neurons 
(Alavian et al., 2009). These results suggest that the suppression of ERK activity could 
promote p75NTR-mediated cell death. Similarly, our experiments revealed the 
treatment of LUHMES neurons with 6-OHDA resulted in a suppression of ERK activity. 
However, due to the downregulation of the p75NTR full-length receptor following 6-
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OHDA treatment, it cannot be determined whether ERK suppression is mediated by 
p75NTR. The knockdown of p75NTR expression in double mutant Engrailed neurons 
allowed ERK activation to occur, thereby suggesting a relationship between the loss of 
ERK activity and upregulation of p75NTR expression (Alavian et al., 2009). Therefore, 
further investigations utilizing p75NTR knockout neurons are needed in order to 
determine if p75NTR suppresses ERK activity in dopaminergic neurons exposed to 
oxidative stress.  
The regulation of p75NTR-mediated cell death has been heavily indicated to 
occur in response to neurotrophin or proneurotrophin binding. However, 
overexpression of p75NTR cleavage fragments or p75NTR recombinant mutants have 
displayed the ability to induce apoptotic signaling pathways such as JNK 
phosphorylation and caspase-3 cleavage in a ligand independent manner (M. Vilar et 
al., 2009). Relative to these results, sympathetic neurons pre-treated with a ligand-
blocking antibody specific for the p75NTR extracellular domain (α-p75NTR ECD) failed to 
protect neurons from HNE-induced apoptosis, thereby revealing p75NTR mediates 
these events in a ligand-independent mechanism. In our investigations, we observed 
similar results when LUHMES neurons were exposed to 6-OHDA toxicity. Blockage of 
the p75NTR ligand-binding domain using α-p75NTR ECD failed to protect LUHMES 
neurons from 6-OHDA-induced death. Thus, our results suggest if p75NTR is responsible 
for promoting apoptosis of dopaminergic neurons in response to oxidative stress, then 
the mechanism at which this occurs is ligand-independent. Previous investigations 
have demonstrated p75NTR activation can occur in the absence of ligands due to the 
expression of a highly conserved cysteine residue 257 (Cys257) in the transmembrane 
domain of the receptor (M. Vilar et al., 2009). It was initially believed p75NTR could only 
dimerize in response to neurotrophin binding by way of the proposed ‘snail-tong’ 
model (Marçal Vilar et al., 2009). This model suggests that when a neurotrophin binds 
to p75NTR, the receptor dimerizes, causing the intracellular domains to separate in a 
scissors-like movement. However, the Cys257 residue has been shown to enable p75NTR 
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to dimerize at the plasma membrane independent of ligand-binding due to disulfide 
bonding of the juxtamembrane of the receptor. The precise reason as to why this 
occurs is unknown, but it is believed that various cysteine residues, such as Cys257 may 
induce different degrees of separation between the p75NTR intracellular domains. 
Additionally, it is suggested that p75NTR may undergo an array of conformational 
changes that each have its own particular function (M. Vilar et al., 2009). Therefore, it 
is possible that oxidative stress stimulates p75NTR to undergo a conformational change 




CONCLUSIONS AND FUTURE DIRECTIONS 
4.1 Conclusions 
This thesis project aimed to investigate the activation of p75NTR in 
dopaminergic neurons subjected to oxidative stress. Our findings exhibit a novel 
mechanism of p75NTR activation in dopaminergic neurons exposed to oxidative stress. 
The induction of p75NTR cleavage occurred following 6-OHDA toxicity along with 
dopaminergic neuronal cell death. Furthermore, inhibition of the p75NTR extracellular 
domain failed to protect neurons from 6-OHDA induced death. These results provide 
evidence that p75NTR could be a potential contributor of the degeneration of 
dopaminergic neurons in Parkinson’s disease. However, further investigations are 
needed to fully clarify the pro-apoptotic role of p75NTR in this neuronal population 
under stressful conditions, determine if p75NTR proteolysis contributes to oxidative 
stress-induced death, and to identify activation of signaling cascades downstream of 
p75NTR.     
4.2 Future Studies  
 Our results provide a novel mechanism of p75NTR activation in dopaminergic 
neurons exposed to oxidative stress, which is relative to sympathetic neurons exposed 
to the same conditions. However, the functional role of p75NTR in sympathetic neurons 
subjected to HNE-induced oxidative stress is more pronounced due to the utilization of 
cleavage inhibitors and p75NTR knockout mice (Kraemer et al., 2014). These 
investigations discovered p75NTR proteolytic cleavage contributed to the induction of 
apoptosis and axonal degeneration in sympathetic neurons by HNE due to the 
significant amount of protection sympathetic neurons experienced from HNE-induced 
degeneration following TACE cleavage (Kraemer et al., 2014). Several studies have 
indicated the functions of p75NTR are cell-type-specific, meaning that the receptor is 
able to elicit distinct responses in different cell types. For example, hippocampal 
neurons and cerebral granule neurons exhibit different patterns of p75NTR cleavage, 
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which is suggested to underlie the different p75NTR signaling activities in the two 
neuronal cell types (Vicario, Kisiswa, Tann, Kelly, & Ibanez, 2015).  Given the discovery 
that p75NTR cleavage contributes to the induction of HNE-induced death in sympathetic 
neurons, pharmacological investigations using TACE and γ-secretase inhibitors need to 
be conducted using dopaminergic neurons in order to understand the functional 
significance of p75NTR proteolysis in oxidative-stress induced death.   
 Several investigations have demonstrated that the death signal initiated by 
p75NTR occurs through the downstream induction of the stress-activated kinase c-Jun 
N-terminal kinase (JNK) pathway. JNK has been shown to promote pro-apoptotic 
p75NTR signaling in various cell types such as sympathetic neurons (Palmada et al., 
2002), cerebral granule neurons (Vicario et al., 2015), oligodendrocytes (Casaccia-
Bonnefil et al., 1996), Schwann cells (Yeiser, 2004), and hippocampal neurons 
(Friedman, 2000). Therefore, it would beneficial to assess if JNK activation occurs in 
dopaminergic neurons exposed to oxidative stress. These results could provide 
evidence that JNK contributes to the degeneration of dopaminergic neurons.  
 The utilization of p75NTR knockout neurons further confirmed the contribution 
of p75NTR in the death of sympathetic neurons due to the significant protection of 
knockout neurons from HNE-induced apoptosis (Kraemer et al., 2014). Therefore, the 
assessment of death in p75NTR knockout dopaminergic neurons subjected to oxidative 
stress should be performed. These experiments would further define the contributions 
of p75NTR signaling in the degeneration of brain regions vulnerable to oxidative stress 
as well as provide insight on the possible contribution of p75NTR in oxidative stress-
associated disorders such as Parkinson’s disease. Furthermore, p75NTR knockout 
neurons would also determine if p75NTR is directly responsible for activating JNK in 
dopaminergic neurons subjected to oxidative stress.  
 The ability of p75NTR to induce apoptosis is the most studied function of the 
receptor. However, p75NTR has also been shown to promote axonal degeneration 
during the development of sympathetic (Singh et al., 2008) and cholinergic neurons 
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(Park et al., 2010). Furthermore, p75NTR has been established as a promoter of axonal 
degeneration in sympathetic neurons exposed to oxidative stress due to the 
remarkable protection that sympathetic neurons lacking p75NTR experienced following 
HNE treatment (Kraemer et al., 2014). It has not been determined if p75NTR functions 
similarly in brain neurons. Axonal degeneration has been characterized as an 
important step in the pathomechanism of neurodegenerative conditions (Lingor, Koch, 
Tönges, & Bähr, 2012). The process has been suggested to occur early in the course of 
neurodegenerative diseases, providing a potential target for therapeutic strategies. 
Parkinson’s disease, a neurological condition related to oxidative stress, has been 
shown to be associated with axonal degeneration (Lingor et al., 2012). Additionally, 
axonal degeneration in Parkinson’s disease has been suggested to precede neuronal 
death (Lingor et al., 2012). Therefore it would be essential to investigate if p75NTR 
contributes to the axonal degeneration of dopaminergic neurons by exposing wild-
type and p75NTR knockout dopaminergic neurons to 6-OHDA and then analyzing the 
amount of axonal degeneration that occurred following treatment.  
 Trk receptors induce the activation of several cell survival pathways such as 
PI3K/Akt, Ras/ERK, and phospholipase-C. A previous investigation has exhibited a 
correlation between high expression of p75NTR and the suppression of ERK activity in 
mesencephalic dopaminergic neurons deficient in the Engrailed genes (Alavian et al., 
2009). However, there was not a significant difference in the activation of the Akt 
pathway in the deficient neurons compared to wild-type neurons. Furthermore, there 
were not any signs of differential activation in the JNK pathway between Engrailed 
deficient neurons compared to wild-type neurons (Alavian et al., 2009). Our lab has 
begun investigating the suppression of Trk signaling in dopaminergic neurons exposed 
to oxidative stress and so far we have observed that 6-OHDA causes a suppression of 
ERK activity. However, future investigations should include analysis of the Akt and 
phospholipase-C pathways to further characterize if all Trk signaling pathways are 
suppressed under conditions of oxidative stress. Furthermore, future investigations 
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should also utilize dopaminergic neurons deficient in p75NTR to determine if p75NTR 
plays a role in the suppression of Trk signaling in dopaminergic neurons under 
conditions of oxidative stress.  
 Numerous reports have shown Alzheimer’s disease is associated with oxidative 
stress. The hippocampus, a brain region known to play a critical role in learning and 
memory (Sakaguchi, Kadoshima, Soen, Narii, & Ishida, 2015), is highly degenerated by 
Alzheimer’s disease. Analyses of postmortem brain tissue of Alzheimer’s disease 
patients have shown increased levels of p75NTR within the hippocampus (Ito et al., 
2016). Furthermore, the loss of p75NTR expression in a murine model of Alzheimer’s 
disease was shown to reduce Alzheimer’s-associated behavioral symptoms (Murphy et 
al., 2015). Our lab recently began evaluating the effects of HNE on hippocampal 
neuron viability. HNE is a product of lipid peroxidation and it is commonly used to 
mimic oxidative stress in neurons due to its reputation as a key mediator of neuronal 
apoptosis during oxidative stress. Our preliminary results exhibited a dose-dependent 
effect of HNE on hippocampal neuron survival. Furthermore, we observed the 20 μ  
concentration of HNE was able to cause almost 100 percent cell death. However, 
additional experimental trials are needed to confirm 20 μ  HNE is the maximally 
effective dose. This finding will then allow our lab to evaluate the effect of oxidative 
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